WO2011080503A2 - Simulated moving bed chromatographic separation process - Google Patents
Simulated moving bed chromatographic separation process Download PDFInfo
- Publication number
- WO2011080503A2 WO2011080503A2 PCT/GB2010/002339 GB2010002339W WO2011080503A2 WO 2011080503 A2 WO2011080503 A2 WO 2011080503A2 GB 2010002339 W GB2010002339 W GB 2010002339W WO 2011080503 A2 WO2011080503 A2 WO 2011080503A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zone
- pufa product
- column
- typically
- eluent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1814—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns recycling of the fraction to be distributed
- B01D15/1821—Simulated moving beds
- B01D15/185—Simulated moving beds characterized by the components to be separated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/10—Refining fats or fatty oils by adsorption
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/12—Refining fats or fatty oils by distillation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
Definitions
- the present invention relates to an improved chromatographic fractionation process for purifying polyunsaturated fatty acids (PUFAs) and derivatives thereof.
- PUFAs polyunsaturated fatty acids
- the present invention relates to an improved simulated or actual moving bed chromatographic separation process for purifying PUFAs and derivatives thereof.
- Fatty acids in particular PUFAs, and their derivatives are precursors for biologically important molecules, which play an important role in the regulation of biological functions such as platelet aggregation, inflammation and immunological responses.
- PUFAs and their derivatives may be therapeutically useful in treating a wide range of pathological conditions including CNS conditions; neuropathies, including diabetic neuropathy; cardiovascular diseases; general immune system and
- inflammatory conditions including inflammatory skin diseases.
- PUFAs are found in natural raw materials, such as vegetable oils and marine oils. Such PUFAs are however, frequently present in such oils in admixture with saturated fatty acids and numerous other impurities. PUFAs should therefore desirably be purified before nutritional or pharmaceutical uses.
- PUFAs are extremely fragile. Thus, when heated in the presence of oxygen, they are prone to isomerization, peroxidation and oligomerization. The fractionation and purification of PUFA products to prepare pure fatty acids is therefore difficult. Distillation, even under vacuum, can lead to non-acceptable product degradation.
- the column contains a packing of a porous material (generally called the stationary phase) exhibiting a high permeability to fluids.
- the percolation velocity of each component of the mixture depends on the physical properties of that component so that the components exit from the column successively and selectively. Thus, some of the components tend to fix strongly to the stationary phase and thus will percolate slowly, whereas others tend to fix weakly and exit from the column more quickly.
- Many different stationary bed chromatographic systems have been proposed and are used for both analytical and industrial production purposes.
- a simulated moving bed system consists of a number of individual columns containing adsorbent which are connected together in series. Eluent is passed through the columns in a first direction. The injection points of the feedstock and the eluent, and the separated component collection points in the system, are periodically shifted by means of a series of valves. The overall effect is to simulate the operation of a single column containing a moving bed of the solid adsorbent.
- a simulated moving bed system consists of columns which, as in a conventional stationary bed system, contain stationary beds of solid adsorbent through which eluent is passed, but in a simulated moving bed system the operation is such as to simulate a continuous countercurrent moving bed.
- An actual moving bed system is similar in operation to a simulated moving bed system. However, rather than shifting the injection points of the feed mixture and the eluent, and the separated component collection points by means of a system of valves, instead a series of adsorption units (i.e. columns) are physically moved relative to the feed and drawoff points. Again, operation is such as to simulate a continuous countercurrent moving bed. Processes and equipment for actual moving bed chromatography are described in several patents, including US 6,979,402, US 5,069,883 and US 4,764,276, the entirety of which are incorporated herein by reference.
- Simulated and actual moving bed technology is generally only suitable for separating binary mixtures. Thus, a more polar component will move with the eluent, and be collected as a raffinate stream, and a less polar component will move with the adsorbent, and be collected as an extract stream. It is therefore difficult to use simulated or actual moving bed technology to separate a desired product from a crude mixture containing both polar and non-polar impurities. This limits the applicability of such techniques in purifying PUFA products from fish oils, for example.
- Fig. 1 schematically illustrated in Fig. 1 is limited to binary fractionation.
- a PUFA product can be effectively purified with a single simulated or actual moving bed apparatus using an aqueous alcohol eluent.
- the present invention therefore provides a chromatographic separation process for recovering a polyunsaturated fatty acid (PUFA) product, from a feed mixture, which process comprises introducing the feed mixture to a simulated or actual moving bed chromatography apparatus having a plurality of linked
- chromatography columns containing, as eluent, an aqueous alcohol
- the apparatus has a plurality of zones comprising at least a first zone and second zone, each zone having an extract stream and a raffinate stream from which liquid can be collected from said plurality of linked chromatography columns, and wherein (a) a raffinate stream containing the PUFA product together with more polar components is collected from a column in the first zone and introduced to a nonadjacent column in the second zone, and/or (b) an extract stream containing the PUFA product together with less polar components is collected from a column in the second zone and introduced to a nonadjacent column in the first zone, said PUFA product being separated from different components of the feed mixture in each zone.
- PUFA product obtainable by the process of the present invention.
- the PUFA products produced by the process of the present invention are produced in high yield, and have high purity. Further, the content of the distinctive impurities which typically arise from distillation of PUFAs is very low.
- isomeric impurities is used to denote those impurities typically produced during the distillation of PUFA-containing natural oils. These include PUFA isomers, peroxidation and oligomerization products.
- Figure 1 illustrates the basic principles of a simulated or actual moving bed process for separating a binary mixture.
- Figure 2 illustrates a first preferred embodiment of the invention which is suitable for separating EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 3 illustrates a second preferred embodiment of the invention which is suitable for separating DHA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 4 illustrates in more detail the first preferred embodiment of the invention which is suitable for separating EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 5 illustrates in more detail the second preferred embodiment of the invention which is suitable for separating DHA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 6 illustrates in more detail an alternative method for the first preferred embodiment of the invention which is suitable for separating EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 7 illustrates in more detail an alternative method for the second preferred embodiment of the invention which is suitable for separating DHA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 8 illustrates a particularly preferred embodiment of the invention for purifying EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 9 illustrates an alternative method for a particularly preferred embodiment of the invention for purifying EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 10 illustrates a particularly preferred embodiment of the invention for purifying EPA from faster and slower running components (i.e. more polar and less polar impurities).
- Figure 11 shows a GC analysis of an EPA product produced in accordance with the invention..
- Figure 12 shows GC FAMES traces of first extract and raffinate streams obtained in accordance with the invention.
- Figure 13 shows GC FAMES traces of second extract and raffinate streams obtained in accordance with the invention.
- Figure 14 shows a GC FAMES trace of a DHA product produced in accordance with the invention.
- Figure 15 shows a GC FAMES trace of a DHA product produced by distillation.
- PUFA polyunsaturated fatty acid
- PUFA derivative is a PUFA in the form of a mono-, di- or triglyceride, ester, phospholipid, amide, lactone, or salt.
- Triglycerides and esters are preferred.
- Esters are more preferred.
- Esters are typically alkyl esters, preferably Ci- C 6 alkyl esters, more preferably CrC 4 alkyl esters. Examples of esters include methyl and ethyl esters. Ethyl esters are most preferred.
- PUFA product refers to a product comprising one or more polyunsaturated fatty acids (PUFAs), and/or derivatives thereof, typically of nutritional or pharmaceutical significance.
- PUFA product is a single PUFA or derivative thereof.
- the PUFA product is a mixture of two or more PUFAs or derivatives thereof, for example two.
- zone refers to a plurality of linked chromatography columns containing, as eluent, an aqueous alcohol, and having one or more injection points for a feed mixture stream, one or more injection points for water and/or alcohol, a raffinate take-off stream from which liquid can be collected from said plurality of linked chromatography columns, and an extract take-off stream from which liquid can be collected from said plurality of linked chromatography columns.
- each zone has only one injection point for a feed mixture.
- each zone has only one injection point for the aqueous alcohol eluent.
- each zone has two or more injection points for water and/or alcohol.
- raffinate is well known to the person skilled in the art. In the context of actual and simulated moving bed chromatography it refers to the stream of
- a raffinate stream is typically enriched with more polar components, and depleted of less polar components compared with a feed stream.
- extract is well known to the person skilled in the art. In the context of actual and simulated moving bed chromatography it refers to the stream of
- an extract stream is typically enriched with less polar components, and depleted of more polar components compared with a feed stream.
- nonadjacent when applied to columns in the same apparatus refers to columns separated by one or more columns, preferably 3 or more columns, more preferably 5 or more columns, most preferably about 5 columns.
- the raffinate stream collected from the first zone is the feed mixture for the second zone.
- an extract stream containing the PUFA product together with less polar components is collected from a column in the second zone and introduced to a nonadjacent column in the first zone
- the extract stream collected from the second zone is the feed mixture in the first zone.
- the PUFA product comprises at least one ⁇ -3 or co-6 PUFA, preferably at least one ⁇ -3 PUFA.
- Examples of ⁇ -3 PUFAs include alpha-linolenic acid (ALA), stearidonic acid (SDA), eicosatrienoic acid (ETE), eicosatetraenoic acid (ETA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DP A) and docosahexaenoic acid (DHA).
- ALA alpha-linolenic acid
- SDA stearidonic acid
- ETE eicosatrienoic acid
- ETA eicosatetraenoic acid
- EPA eicosapentaenoic acid
- DP A docosapentaenoic acid
- DHA docosahexaenoic acid
- SDA, EPA, DPA and DHA are preferred. EPA and DHA are more preferred.
- ⁇ -6 PUFAs examples include linoleic acid (LA), gamma-linolenic acid (GLA), eicosadienoic acid, dihomo-gamma-linolenic acid (DGLA), arachidonic acid (ARA), docosadienoic acid, adrenic acid and docosapentaenoic (co-6) acid.
- LA, ARA, GLA and DGLA are preferred.
- the PUFA product is EPA and/or EPA ethyl ester (EE)
- the PUFA product is DHA and/or EPA ethyl ester (EE).
- the PUFA product is a mixture of EPA and DHA and/or EPA EE and DHA EE.
- Suitable feed mixtures for fractionating by the process of the present invention may be obtained from natural sources including vegetable and animal oils and fats, and from synthetic sources including oils obtained from genetically modified plants, animals and micro organisms including yeasts.
- Examples include fish oils, algal and microalgal oils and plant oils, for example borage oil, Echium oil and evening primrose oil.
- the feed mixture is a fish oil.
- the feed mixture is an algal oil.
- Algal oils are particularly suitable when the desired PUFA product is EPA and/or DHA.
- Genetically modified Safflower oil is particularly suitable when the desired PUFA product is GLA.
- Genetically modified yeast is particularly suitable when the desired PUFA product is EPA.
- the feed mixture may undergo chemical treatment before fractionation by the process of the invention.
- glyceride transesterification or glyceride hydrolysis followed in certain cases by selective processes such as crystallisation, molecular distillation, urea fractionation, extraction with silver nitrate or other metal salt solutions, iodolactonisation or supercritical fluid fractionation.
- the feed mixtures typically contain the PUFA product and at least one more polar component and at least one less polar component.
- the less polar components have a stronger adherence to the adsorbent used in the process of the present invention than does the PUFA product.
- such less polar components typically move with the solid adsorbent phase in preference to the liquid eluent phase.
- the more polar components have a weaker adherence to the adsorbent used in the process of the present invention than does the PUFA product.
- such more polar components typically move with the liquid eluent phase in preference to the solid adsorbent phase.
- more polar components will be separated into a raffinate stream, and less polar components will be separated into an extract stream.
- Examples of the more and less polar components include (1) other compounds occurring in natural oils (e.g. marine oils or vegetable oils), (2) byproducts formed during storage, refining and previous concentration steps and (3) contaminants from solvents or reagents which are utilized during previous concentration or purification steps.
- Examples of (1) include other unwanted PUFAs; saturated fatty acids; sterols, for example cholesterol; vitamins; and environmental pollutants, such as
- PCB polychlorobiphenyl
- PAH polyaromatic hydrocarbon
- Examples of (2) include isomers and oxidation or decomposition products from the PUFA product, for instance, auto-oxidation polymeric products of fatty acids or their derivatives.
- Examples of (3) include urea which may be added to remove saturated or mono- unsaturated fatty acids from the feed mixture.
- the feed mixture is a PUFA-containing marine oil, more preferably a marine oil comprising EPA and/or DHA.
- a typical feed mixture for preparing concentrated EPA by the process of the present invention comprises 50-75% EPA, 0 to 10% DHA, and other components including other essential ⁇ -3 and o-6 fatty acids.
- a preferred feed mixture for preparing concentrated EPA by the process of the present invention comprises 55% EPA, 5% DHA, and other components including other essential co-3 and co-6 fatty acids. DHA is less polar than EPA.
- a typical feed mixture for preparing concentrated DHA by the process of the present invention comprises 50-75% DHA, 0 to 10% EPA, and other components including other essential co-3 and ⁇ -6 fatty acids.
- a preferred feed mixture for preparing concentrated DHA by the process of the present invention comprises 75% DHA, 7% EPA and other components including other essential ⁇ -3 and co-6 fatty acids. EPA is more polar than DHA.
- a typical feed mixture for preparing a concentrated mixture of EPA and DHA by the process of the present invention comprises greater than 33% EPA, and greater than 22% DHA.
- the process of the invention requires a plurality of zones in said chromatography apparatus. Typically, two or more zones are used.
- the number of zones is not particularly limited, but in general there are 2 to 5 zones.
- the components separated in each zone of the apparatus used in the process of the present invention have different polarities.
- aqueous alcohol eluent present in each zone has a different
- the present invention typically provides a chromatographic separation process for recovering a polyunsaturated fatty acid (PUFA) product, from a feed mixture, which process comprises introducing the feed mixture to a simulated or actual moving bed chromatography apparatus having a plurality of linked chromatography columns containing, as eluent, an aqueous alcohol, wherein the apparatus has a first zone and a second zone, each zone having an extract stream and a raffinate stream from which liquid can be collected from said plurality of linked chromatography columns, and wherein (a) a raffinate stream containing the PUFA product together with more polar components is collected from a column in the first zone and introduced to a nonadjacent column in the second zone, and/or (b) an extract stream containing the PUFA product together with less polar components is collected from a column in the second zone and introduced to a nonadjacent column in the first zone, said PUFA product being separated from less
- the apparatus used in the process of the present invention contains two zones
- the eluent in the first zone contains more alcohol than the eluent in the second zone
- the second zone is downstream of the first zone with respect to the flow of eluent in the system.
- the eluent in the system typically moves from the first zone to the second zone.
- the solid adsorbent phase typically moves from the second zone to the first zone.
- the two zones do not overlap, i.e. there are no chromatographic columns which are in both zones.
- the apparatus has a first zone, a second zone and a third zone.
- the watenalcohol ratios of the aqueous alcohol eluent present in the first, second and third zones are typically different. As will be evident to one skilled in the art, this has the consequence that impurities having different polarities can be removed in each zone.
- the eluent in the first zone contains more alcohol than the eluent in the second zone and the third zone and the first zone is upstream of the second and third zones with respect to the flow of eluent in the system.
- the eluent in the second zone contains more alcohol than the eluent in the third zone and the second zone is upstream of the third zone with respect to the flow of eluent in the system.
- said PUFA product is separated from components of the feed mixture which are less polar than the PUFA product.
- said PUFA product is separated from components of the feed mixture which are less polar than the PUFA product but more polar than the components separated in the first zone.
- said PUFA product is separated from components of the feed mixture which are more polar than the PUFA product.
- said PUFA product is separated from components of the feed mixture which are less polar than the PUFA product, in the second zone, said PUFA product is separated from components of the feed mixture which are more polar than the PUFA product, and in the third zone, said PUFA product is separated from components of the feed mixture which are more polar than the PUFA product and also more polar than the components separated in the second zone.
- Such a setup having three zones would be suitable for separating EPA and DHA from a mixture containing impurities which are less polar than DHA and EPA and also containing impurities which are more polar than EPA.
- the components which are less polar than DHA and EPA are removed as an extract stream and a raffinate stream comprising DHA, EPA and components which are more polar than EPA is collected and introduced into the second zone.
- DHA is removed as an extract stream and a raffinate stream comprising EPA and components which are more polar than EPA is collected and introduced into the third zone.
- the components which are more polar than EPA are removed as a raffinate stream and purified EPA is collected as an extract stream.
- the purified EPA is the purified PUFA product.
- a secondary PUFA may also be recovered.
- the secondary PUFA is the DHA collected as the extract stream from the second zone.
- an additional secondary PUFA product is collected in the chromatographic separation process of the invention.
- the PUFA product is EPA and the additional secondary PUFA product is DHA.
- the apparatus is configured to collect a PUFA product which is a concentrated mixture of EPA and DHA.
- a feed mixture is used which contains EPA, DHA, components which are more polar than EPA and DHA, and components which are less polar than EPA and DHA.
- less polar material than EPA and DHA is removed.
- material which is more polar than EPA and DHA is removed, and a concentrated mixture of EPA and DHA is collected as the PUFA product.
- Any known simulated or actual moving bed chromatography apparatus may be utilised for the purposes of the method of the present invention, as long as the apparatus is configured with the multiple, in particular two, zones which characterise the process of the present invention.
- the number of columns used in the apparatus is not particularly limited. A skilled person would easily be able to determine an appropriate number of columns to use.
- the number of columns is typically 8 or more, preferably 15 or more. In a more preferred embodiment 15 or 16 columns are used. In another more preferred embodiment, 19 or 20 columns are used. In other more preferred embodiments, 30 or more columns are used. Typically, there are no more than 50 columns, preferably no more than 40.
- Each zone typically consists of an approximately equal share of the total number of columns.
- each zone typically consists of approximately half of the total number of chromatographic columns in the system.
- the first zone typically comprises 4 or more, preferably 8 or more, more preferably about 8 columns.
- the second zone typically comprises 4 or more, preferably 7 or more, more preferably 7 or 8 columns.
- the dimensions of the columns used in the apparatus are not particularly limited, and will depend on the volume of feed mixture to be purified. A skilled person would easily be able to determine appropriately sized columns to use.
- the diameter of each column is typically between 10 and 500mm, preferable between 25 and 250mm, more preferable between 50 and 100 mm, and most preferably between 70 and 80 mm.
- the length of each column is typically between 10 and 200 cm, preferably between 25 and 150cm, more preferably between 70 and 110 cm, and most preferably between 80 and 100 cm.
- the columns in each zone typically have identical dimensions but may, for certain applications, have different dimensions.
- the flow rates to the column are limited by maximum pressures across the series of columns and will depend on the column dimensions and particle size of the solid phases.
- One skilled in the art will easily be able to establish the required flow rate for each column dimension to ensure efficient desorption. Larger diameter columns will in general need higher flows to maintain linear flow through the columns.
- the flow rate of eluent into the first zone is from 1 to 4.5L/min, preferably from 1.5 to 2.5 L/min.
- the flow rate of the extract from the first zone is from 0.1 to 2.5L/min, preferably from 0.5 to 2.25 L/min.
- the flow rate of recycle is typically from 0.7 to 1.4 L/min, preferably about 1 L/min.
- the flow rate of the raffinate from the first zone is from 0.2 to 2.5 L/min, preferably from 0.3 to 2.0 L/min.
- the flow rate of recycle is typically from 0.3 to 1.0 L/min, preferably about 0.5 L/min.
- the flow rate of introduction of the feed mixture into the first zone is from 5 to 150 mL/min, preferably from 10 to 100 mL/min, more preferably from 20 to 60 mL/min.
- the flow rate of eluent into the second zone is from 1 to 4 L/min, preferably from 1.5 to 3.5 L/min.
- the flow rate of the extract from the second zone is from from 0.5 to 2 L/min, preferably from 0.7 to 1.9 L/min.
- the flow rate of recycle is typically from 0.6 to 1.4 L/min, preferably from 0.7 to 1.1 L/min, more preferably about 0.9 L/min.
- the flow rate of the raffinate from the second zone is from 0.5 to 2.5 L/min, preferably from 0.7 to 1.8 L/min, more preferably about 1.4 L/min.
- references to rates at which liquid is collected or removed via the various extract and raffinate streams refer to volumes of liquid removed in an amount of time, typically L/minute.
- references to rates at which liquid is recycled back into the same zone, typically to an adjacent column in the same zone refer to volumes of liquid recycled in an amount of time, typically L/minute.
- part of one or more of the extract stream from the first zone, the raffinate stream from the first zone, the extract stream from the second zone, and the raffinate stream from the second zone are recycled back into the same zone, typically into an adjacent column in the same zone.
- This recycle is different from the feeding of an extract or raffinate stream into a non- adjacent column in another zone. Rather, the recycle involves feeding part of the extract or raffinate stream out of a zone back into the same zone, typically into an adjacent column in the same zone.
- the rate at which liquid collected via the extract or raffinate stream from the first or second zones is recycled back into the same zone is the rate at which liquid collected via that stream is fed back into the same zone, typically into an adjacent column in the same zone.
- the rate of recycle of extract in the first zone is the rate at which extract collected from the bottom of column 2 is fed into the top of column 3, i.e. the flow rate of liquid into the top of column 3.
- the rate of recycle of extract in the second zone is the rate at which extract collected at the bottom of column 10 is fed into the top of column 11, i.e. the flow rate of liquid into the top of column 1 1.
- Recycle of the extract and/or raffinate streams is typically effected by feeding the liquid collected via that stream into a container, and then pumping an amount of that liquid from the container back into the same zone.
- the rate of recycle of liquid collected via a particular extract or raffinate stream, typically back into an adjacent column in the same zone is the rate at which liquid is pumped out of the container back into the same zone, typically into an adjacent column.
- the amount of liquid being introduced into a zone via the eluent and feedstock streams is balanced with the amount of liquid removed from a zone, and recycled back into the same zone.
- the flow rate of eluent (desorbent) into the first or second zone (D) is equal to the rate at which liquid collected via the extract stream from that zone accumulates in a container (E1/E2) added to the rate at which extract is recycled back into the same zone (D-E1/D-E2).
- the rate at which extract is recycled back into a zone (D-E1/D-E2) added to the rate at which feedstock is introduced into a zone (F/Rl) is equal to the rate at which liquid collected via the raffinate stream from that zone accumulates in a container (R1/R2) added to the rate at which raffinate is recycled back into the same zone (D+F-El- R1/D+R1-E2-R2).
- the rate at which liquid collected from a particular extract or raffinate stream from a zone accumulates in a container can also be thought of as the net rate of removal of that extract or raffinate stream from that zone.
- the rate at which liquid collected via the extract stream out of the first zone is recycled back into the first zone differs from the rate at which liquid collected via the extract stream out of the second zone is recycled back into the second zone, and/or the rate at which liquid collected via the raffinate stream out of the first zone is recycled back into the first zone differs from the rate at which liquid collected via the raffinate stream out of the second zone is recycled back into the second zone.
- Varying the rate at which liquid collected via the extract and/or raffinate streams in each zone is recycled back into the same zone has the effect of varying the amount of more polar and less polar components present in the other extract and raffinate streams.
- a lower extract recycle rate results in fewer of the less polar components in that zone being carried through to the raffinate stream in that zone.
- a higher extract recycle rate results in more of the less polar components in that zone being carried through to the raffinate stream in that zone. This can be seen, for example, in the specific embodiment of the invention shown in figure 6.
- the rate at which liquid collected via the extract stream in the first zone is recycled back into the same zone (D-El) will affect to what extent any of component A is carried through to the raffinate stream in the first zone (Rl).
- the rate at which liquid collected via the extract stream from the first zone is recycled back into the first zone is faster than the rate at which liquid collected via the extract stream from the second zone is recycled back into the second zone.
- a raffinate stream containing the PUFA product together with more polar components is collected from a column in the first zone and introduced to a nonadjacent column in the second zone, and the rate at which liquid collected via the extract stream from the first zone is recycled back into the first zone is faster than the rate at which liquid collected via the extract stream from the second zone is recycled back into the second zone.
- the rate at which liquid collected via the extract stream from the first zone is recycled back into the first zone is slower than the rate at which liquid collected via the extract stream from the second zone is recycled back into the second zone.
- the rate at which liquid collected via the raffinate stream from the second zone is recycled back into the second zone is faster than the rate at which liquid collected via the raffinate stream from the first zone is recycled back into the first zone.
- an extract stream containing the PUFA product together with less polar components is collected from a column in the second zone and introduced to a nonadjacent column in the first zone, and the rate at which liquid collected via the raffinate stream from the second zone is recycled back into the second zone is faster than the rate at which liquid collected via the raffinate stream from the first zone is recycled back into the first zone.
- the rate at which liquid collected via the raffinate stream from the second zone is recycled back into the second zone is slower than the rate at which liquid collected via the raffinate stream from the first zone is recycled back into the first zone.
- the step time i.e. the time between shifting the points of injection of the feed mixture and eluent, and the various take off points of the collected fractions, is not particularly limited, and will depend on the number and dimensions of the columns used, and the flow rate through the apparatus. A skilled person would easily be able to determine appropriate step times to use in the process of the present invention.
- the step time is typically from 100 to 1000 seconds, preferably from 200 to 800 seconds, more preferably from about 250 to about 750 seconds.
- Each chromatographic column may contain the same or a different adsorbent.
- each column contains the same adsorbent.
- Examples of such commonly used materials are polymeric beads, preferably polystyrene reticulated with DVB (divinylbenzene); and silica gel, preferably reverse phase bonded silica gel with C8 or CI 8 alkanes, especially CI 8. CI 8 bonded reverse phase silica gel is preferred.
- the adsorbent used in the process of the present invention is preferably non-polar.
- the shape of the adsorbent stationary phase material may be, for example, spherical or nonspherical beads, preferably substantially spherical beads.
- Such beads typically have a diameter of 40 to 500 microns, preferably 100 to 500 microns, more preferably 250 to 500 microns, even more preferably 250 to 400 microns, most preferably 250 to 350 microns.
- These preferred particle sizes are somewhat larger than particle sizes of beads used in the past in simulated and actual moving bed processes. Use of larger particles enables a lower pressure of eluent to be used in the system. This, in turn, has advantages in terms of cost savings, efficiency and lifetime of the apparatus. It has surprisingly been found that adsorbent beads of large particle size may be used in the process of the present invention (with their associated advantages) without any loss in resolution.
- the adsorbent typically has a pore size of from 10 to 50 nm, preferably 15 to 45 nm, more preferably 20 to 40 nm, most preferably 25 to 35 nm.
- the eluent used in the process of the present invention is an aqueous alcohol.
- the aqueous alcohol typically comprises water and one or more short chain alcohols.
- the short chain alcohol typically has from 1 to 6 carbon atoms.
- suitable alcohols include methanol, ethanol, n-propanol, i-propanol, n-butanol, i-butanol, s- butanol and t-butanol. Methanol and ethanol are preferred. Methanol is more preferred.
- the eluent is not in a supercritical state.
- the eluent is a liquid.
- the average watenalcohol ratio of the eluent in the entire apparatus is from 0.1 :99.9 to 9:91 parts by volume, preferably from 0.25:99.75 to 7:93 parts by volume, more preferably from 0.5:99.5 to 6:94 parts by volume.
- the eluting power of the eluent in each of the zones is typically different.
- the eluting power of the eluent in the first zone is greater than that of the eluent in the second and subsequent zones. In practice this is achieved by varying the relative amounts of water and alcohol in each zone. Alcohols are generally more powerful desorbers than water.
- the amount of alcohol in the eluent in the first zone is typically greater than the amount of alcohol in the eluent of the second and
- the water:alcohol ratio of the eluent in the first zone is typically from 0: 100 to 5:95 parts by volume, preferably from 0.1 :99.9 to 2.5:97.5 parts by volume, more preferably from 0.25:99.75 to 2:98 parts by volume, and most preferably from 0.5:99.5 to 1.5:98.5 parts by volume.
- the watenalcohol ratio of the eluent in the second zone is typically from 3:97 to 7:93 parts by volume, preferably from 4:96 to 6:94 parts by volume, more preferably from 4.5:95.5 to 5.5:94.5 parts by volume.
- the water: alcohol ratio of the eluent in the first zone is from 0.5:99.5 to 1.5:98.5 parts by volume
- the watenalcohol ratio of the eluent in the second zone is from 4.5:95:5 to 5.5:94.5 parts by volume.
- the watenalcohol ratio of the eluents in each zone may be the same or different.
- the watenalcohol ratio of the eluent in each zone is from
- the watenalcohol ratio of the eluent in the first zone is lower than the watenalcohol ratio of the eluent in the second zone. In another embodiment, the watenalcohol ratio of the eluent in the first zone is higher than the watenalcohol ratio of the eluent in the second zone. In a further embodiment, the watenalcohol ratio of the eluent in the first zone is the same as the watenalcohol ratio of the eluent in the second zone.
- ratios of water and alcohol in each zone referred to above are average ratios within the totality of the zone.
- the watenalcohol ratio of the eluent in each zone is controlled by introducing water and/or alcohol into one or more columns in the zones.
- water is typically introduced more slowly into the first zone than the second zone.
- essentially pure alcohol and essentially pure water may be introduced at different points in each zone. The relative flow rates of these two streams will determine the overall solvent profile across the zone.
- different alcohol/water mixtures may be introduced at different points in each zone. That will involve introducing two or more different alcohol/water mixtures into the zone, each alcohol/water mixture having a different alcohol:water ratio.
- the relative flow rates and relative concentrations of the alcohol/water mixtures in this embodiment will determine the overall solvent profile across the zone.
- the same alcohol/water mixture is introduced to each zone.
- the process of the present invention is conducted at from 15 to 55°C, preferably at from 20 to 40°C, more preferably at about 30°C.
- the process is typically carried out at room temperature, but may be conducted at elevated temperatures.
- the process of the present invention involves introducing a feed stream into one zone (for example the first zone), collecting a first intermediate stream enriched with the PUFA product and introducing the first intermediate stream into another zone (for example the second zone).
- the process involves either (a) collecting a first intermediate stream from the first zone and introducing it into the second zone, or (b) collecting a first intermediate stream from the second zone and introducing it into the first zone.
- the PUFA product can be separated from both more and less polar components in a single process.
- the apparatus has two zones, and the process of the present invention comprises:
- a feed mixture F comprising the PUFA product (B) and more polar (C) and less polar (A) components is introduced into the first zone. In the first zone, the less polar components (A) are removed as extract stream El . The PUFA product (B) and more polar components (C) are removed as raffinate stream Rl . Raffinate stream Rl is then introduced into the second zone. In the second zone, the more polar components (C) are removed as raffinate stream R2. The PUFA product (B) is collected as extract stream E2.
- Figure 4 is identical to Figure 2, except that the points of introduction of the alcohol desorbent (D) and water (W) into each zone are shown.
- the alcohol desorbent (D) and water (W) together make up the eluent.
- the (D) phase is typically essentially pure alcohol, but may, in certain embodiments be an alcohol/water mixture comprising mainly alcohol.
- the (W) phase is typically essentially pure water, but may, in certain embodiments be an alcohol/water mixture comprising mainly water, for example a 98%water/2% methanol mixture.
- FIG. 6 A further illustration of this particularly preferred embodiment is shown in Figure 6.
- an aqueous alcohol desorbent is injected at (D).
- the separation into raffinate and extract stream can be aided by varying the desorbing power of the eluent within each zone. This can be achieved by introducing the alcohol (or alcohol rich) component of the eluent and the water (or water rich) component at different points in each zone.
- the alcohol is introduced upstream of the extract take-off point and the water is introduced between the extract take-off point and the point of introduction of the feed into the zone, relative to the flow of eluent in the system.
- Figure 4 This is shown in Figure 4.
- the separation can be aided by varying the rates at which liquid collected via the extract and raffmate streams from the two zones is recycled back into the same zone.
- the rate at which liquid collected via the extract stream from the first zone is recycled back into the first zone is faster than the rate at which liquid collected via the extract stream from the second zone is recycled back into the second zone; or the watenalcohol ratio of the eluent in the first zone is lower than that in the second zone.
- the first raffmate stream in the first zone is typically removed downstream of the point of introduction of the feed mixture into the first zone, with respect to the flow of eluent in the first zone.
- the first extract stream in the first zone is typically removed upstream of the point of introduction of the feed mixture into the first zone, with respect to the flow of eluent in the first zone.
- the second raffmate stream in the second zone is typically removed downstream of the point of introduction of the first raffmate stream into the second zone, with respect to the flow of eluent in the second zone.
- the second extract stream in the second zone is typically collected upstream of the point of introduction of the first raffmate stream into the second zone, with respect to the flow of eluent in the second zone.
- the alcohol or aqueous alcohol is introduced into the first zone upstream of the point of removal of the first extract stream, with respect to the flow of eluent in the first zone.
- the water when water is introduced into the first zone, the water is introduced into the first zone upstream of the point of introduction of the feed mixture but downstream of the point of removal of the first extract stream, with respect to the flow of eluent in the first zone.
- the alcohol or aqueous alcohol is introduced into the second zone upstream of the point of removal of the second extract stream, with respect to the flow of eluent in the second zone.
- the water when water is introduced into the second zone, the water is introduced into the second zone upstream of the point of introduction of the first raffinate stream but downstream of the point of removal of the second extract stream, with respect to the flow of eluent in the second zone.
- the apparatus has two zones, and the process comprises:
- This particularly preferred embodiment is suitable for purifying DHA from a feed mixture.
- a feed mixture F comprising the PUFA product (B) and more polar (C) and less polar (A) components is introduced into the second zone.
- the more polar components (C) are removed as raffinate stream l .
- the PUFA product (B) and less polar components (A) are collected as extract stream El .
- Extract stream El is then introduced to the first zone.
- the less polar components (A) are removed as extract stream E2.
- the PUFA product (B) is collected as raffinate stream R2.
- FIG 5 is identical to Figure 3, except that the points of introduction of the short chain alcohol desorbent (D) and water (W) into each zone are shown.
- the (D) phase is typically essentially pure alcohol, but may, in certain embodiments be an alcohol/water mixture comprising mainly alcohol.
- the (W) phase is typically essentially pure water, but may, in certain embodiments be an alcohol/water mixture comprising mainly water, for example a 98%water/2% methanol mixture.
- Figure 7 Here there is no separate water injection point, and instead an aqueous alcohol desorbent is injected at (D).
- the rate at which liquid collected via the raffinate stream from the second zone is reintroduced into the second zone is faster than the rate at which liquid collected via the raffinate stream from the first zone is
- the first raffinate stream in the second zone is typically removed downstream of the point of introduction of the feed mixture into the second zone, with respect to the flow of eluent in the second zone.
- the first extract stream in the second zone is typically collected upstream of the point of introduction of the feed mixture into the second zone, with respect to the flow of eluent in the second zone.
- the second raffinate stream in the first zone is typically collected downstream of the point of introduction of the first extract stream into the first zone, with respect to the flow of eluent in the first zone.
- the second extract stream in the first zone is typically removed upstream of the point of introduction of the first extract stream into the first zone, with respect to the flow of eluent in the first zone.
- the alcohol or aqueous alcohol is introduced into the second zone upstream of the point of removal of the first extract stream, with respect to the flow of eluent in the second zone.
- the water is introduced into the second zone upstream of the point of introduction of the feed mixture but downstream of the point of removal of the first extract stream, with respect to the flow of eluent in the second zone.
- the alcohol or aqueous alcohol is introduced into the first zone upstream of the point of removal of the second extract stream, with respect to the flow of eluent in the first zone.
- the water is introduced into the first zone upstream of the point of introduction of the first raffinate stream but downstream of the point of removal of the second extract stream, with respect to the flow of eluent in the first zone.
- the simulated or actual moving bed chromatography apparatus consists of fifteen chromatographic columns. These are referred to as columns 1 to 15.
- the fifteen columns are arranged in series so that the bottom of column 1 is linked to the top of column 2, the bottom of column 2 is linked to the top of column 3 etc. This may optionally be via a holding container, with a recycle stream into the next column.
- the flow of eluent through the system is from column 1 to column 2 to column 3 etc.
- the flow of adsorbent through the system is from column 15 to column 14 to column 13 etc.
- the first zone typically consists of eight adjacent columns, columns 1 to 8, which are connected as discussed above.
- the second zone typically consists of seven columns, columns 9 to 15, which are connected as discussed above.
- the bottom of column 8 in the first zone is linked to the top of column 9 in the second zone.
- a feed mixture F comprising the PUFA product (B) and more polar (C) and less polar (A) components is introduced into the top of column 5 in the first zone.
- Alcohol desorbent is introduced into the top of column 1 in the first zone.
- Water is introduced into the top of column 4 in the first zone.
- the less polar components (A) are removed as extract stream El from the bottom of column 2.
- the PUFA product (B) and more polar components (C) are removed as raffinate stream Rl from the bottom of column 7.
- Raffinate stream Rl is then introduced into the second zone at the top of column 13.
- Alcohol desorbent is introduced into the top of column 9 in the second zone.
- alcohol is typically introduced into the top of column 1 in the first zone.
- water is typically introduced into the top of column 4 in the first zone.
- alcohol is typically introduced into the top of column 9 in the second zone. In this most preferred embodiment, alcohol is typically introduced into the top of column 12 in the second zone.
- the feed stream is typically introduced into the top of column 5 in the first zone.
- a first raffinate stream is typically collected from the bottom of column 7 in the first zone and introduced into the top of column 13 in the second zone.
- the first raffinate stream may optionally be collected in a container before being introduced into column 13.
- a first extract stream is typically removed from the bottom of column 2 in the first zone.
- the first extract stream may optionally be collected in a container and reintroduced into the top of column 3 in the first zone.
- a second raffinate stream is typically removed from the bottom of column 15 in the second zone.
- a second extract stream is typically collected from the bottom of column 10 in the second zone.
- This second extract stream typically contains the purified PUFA product.
- the second extract stream may optionally be collected in a container and reintroduced into the top of column 1 1 in the second zone.
- the wateralcohol ratio in the first zone is lower than the water:alcohol ratio in the second zone.
- a feed mixture F comprising the PUFA product (B) and more polar (C) and less polar (A) components is introduced into the top of column 5 in the first zone.
- Aqueous alcohol desorbent is introduced into the top of column 1 in the first zone.
- the less polar components (A) are removed as extract stream El from the bottom of column 2.
- the PUFA product (B) and more polar components (C) are removed as raffinate stream Rl from the bottom of column 7.
- Raffinate stream Rl is then introduced into the second zone at the top of column 12.
- Aqueous alcohol desorbent is introduced into the top of column 9 in the second zone.
- the more polar components (C) are removed as raffinate stream R2 at the bottom of column 14.
- the PUFA product (B) is collected as extract stream E2 at the bottom of column 10.
- aqueous alcohol is typically introduced into the top of column 1 in the first zone.
- aqueous alcohol is typically introduced into the top of column 9 in the second zone.
- the feed stream is typically introduced into the top of column 5 in the first zone.
- a first raffinate stream is typically collected from the bottom of column 7 in the first zone and introduced into the top of column 12 in the second zone.
- the first raffinate stream may optionally be collected in a container before being introduced into column 12.
- a first extract stream is typically removed from the bottom of column 2 in the first zone.
- the first extract stream may optionally be collected in a container and a portion reintroduced into the top of column 3 in the first zone.
- the rate of recycle of liquid collected via the extract stream from the first zone back into the first zone is the rate at which liquid is pumped from this container into the top of column 3.
- a second raffinate stream is typically removed from the bottom of column 14 in the second zone.
- a second extract stream is typically collected from the bottom of column 10 in the second zone.
- This second extract stream typically contains the purified PUFA product.
- the second extract stream may optionally be collected in a container and a portion reintroduced into the top of column 1 1 in the second zone.
- the rate of recycle of liquid collected via the extract stream from the second zone back into the second zone is the rate at which liquid is pumped from this container into the top of column 11.
- the rate at which liquid collected via the extract stream from the first zone is recycled back into the first zone is typically faster than the rate at which liquid collected via the extract stream from the second zone is recycled back into the second zone.
- the aqueous alcohol eluent is substantially the same in each zone.
- the simulated or actual moving bed chromatography apparatus consists of nineteen chromatographic columns. These are referred to as columns 1 to 19. The fifteen columns are arranged in series so that the bottom of column 1 is linked to the top of column 2, the bottom of column 2 is linked to the top of column 3 etc.
- the flow of eluent through the system is from column 1 to column 2 to column 3 etc.
- the flow of adsorbent through the system is from column 19 to column 18 to column 17 etc.
- the first zone typically consists of ten adjacent columns, columns 1 to 10, which are connected as discussed above.
- the second zone typically consists of eight columns, columns 11 to 19, which are connected as discussed above.
- a feed mixture F comprising the PUFA product (B) and more polar (C) and less polar (A and A') components is introduced into the top of column 7 in the first zone.
- a first desorbent (Dl) comprising 100% alcohol is introduced into the top of column 1 in the first zone.
- a second desorbent (D2) comprising a water/alcohol mixture (preferably 2% methanol and 98% water) is introduced into the top of column 5 in the first zone.
- less polar components ( ⁇ ') and (A) are removed as extract streams ⁇ and El from the bottoms of columns 1 and 4, respectively.
- the PUFA product (B) and more polar components (C) are removed as raffinate stream Rl from the bottom of column 10.
- Raffinate stream Rl is then introduced into the second zone at the top of column 17.
- a second desorbent (D2) comprising a water/alcohol mixture
- alcohol is typically introduced into the top of column 1 in the first zone.
- a 2% MeOH/98% water mixture is typically introduced into the top of column 5 in the first zone.
- a 2% MeOH/98% water mixture is typically introduced into the top of column 1 1 in the second zone.
- the feed stream is typically introduced into the top of column 7 in the first zone.
- a first raffmate stream is typically collected from the bottom of column 10 in the first zone and introduced into the top of column 17 in the second zone.
- the first raffmate stream may optionally be collected in a container before being introduced into column 17.
- extract streams are typically removed from the bottoms of columns 1 and 4 in the first zone.
- the extract stream collected from the bottom or column 4 may optionally be collected in a container and reintroduced into the top of column 5 in the first zone.
- a second raffmate stream is typically removed from the bottom of column 19 in the second zone.
- a second extract stream is typically collected from the bottom of column 14 in the second zone.
- This second extract stream typically contains the purified PUFA product.
- the second extract stream may optionally be collected in a container and reintroduced into the top of column 15 in the second zone.
- the water:alcohol ratio in the first zone is lower than the watenalcohol ratio in the second zone.
- the process of the invention allows much higher purities of PUFA product to be achieved than have been possible with conventional chromatographic techniques.
- PUFA products produced by the process of the invention also have particularly advantageous impurity profiles, which are quite different from those observed in oils prepared by known techniques.
- the present invention therefore also relates to compositions comprising a PUFA product, for example one obtainable by the process of the present invention.
- the present invention also provides a composition comprising a PUFA product, wherein the PUFA product is EPA, the PUFA product is present in an amount greater than 93 wt%, and the total content of ⁇ -6 polyunsaturated fatty acids is up to 0.40 wt%.
- the wt% of a component is relative to the total weight of the composition.
- the PUFA product and co-6 PUFAs are optionally in the form of their alkyl esters, typically ethyl esters.
- the EPA PUFA product is in the form of its ethyl ester.
- the EPA PUFA product is present in an amount greater than 94 wt%, preferably greater than 95 wt%, more preferably greater than 96 wt%, even more preferably greater than 97 wt%, and most preferably greater than 98 wt%.
- the total content of co-6 polyunsaturated fatty acids in this embodiment is up to 0.40 wt%.
- the composition comprises an amount of co-6 polyunsaturated fatty acids in up to this amount.
- the total content of co-6 polyunsaturated fatty acids is up to 0.35 wt%, preferably up to 0.3 wt%, more preferably up to 0.25 wt%, and most preferably up to 0.22 wt%.
- the total content of co-6 polyunsaturated fatty acids is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the content of arachidonic acid is up to 0.25 wt%, preferably up to 0.24 wt%, more preferably up to 0.23 wt%, and most preferably up to 0.22 wt%.
- the composition comprises an amount of arachidonic acid in up to these amounts.
- the total content of arachidonic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of co-3 polyunsaturated fatty acids is greater than 97 wt%, preferably greater than 97.5 wt%, more preferably greater than 97.9 wt%. In certain embodiments, the total content of co-3 polyunsaturated fatty acids is greater than 99 wt%.
- the total content of DHA is up to 1 wt%, preferably up to 0.6 wt%, more preferably up to 0.3 wt %, most preferably up to 0.2 wt%.
- the composition comprises an amount of DHA in up to these amounts.
- the total content of DHA is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of DHA is up to 0.2 wt%, preferably up to 0.175 wt%, more preferably up to 0.16 wt %.
- the composition comprises an amount of DHA in up to these amounts.
- the total content of DHA is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of a-linolenic acid is up to 1 wt%, preferably up to 0.6 wt%, more preferably up to 0.3 wt %.
- the composition comprises an amount of ⁇ -linolenic acid in up to these amounts.
- the total content of ⁇ -linolenic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of ⁇ -linolenic acid is up to 0.35 wt%, preferably up to 0.3 wt%, more preferably up to 0.29 wt %.
- the composition comprises an amount of ⁇ -linolenic acid in up to these amounts.
- the total content of ⁇ -linolenic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of stearidonic acid is up to 1 wt%, preferably up to 0.6 wt%, more preferably up to 0.3 wt %.
- the composition comprises an amount of stearidonic acid in up to these amounts.
- the total content of stearidonic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of stearidonic acid is up to 0.4 wt%, preferably up to 0.35 wt%, more preferably up to 0.34 wt %.
- the composition comprises an amount of stearidonic acid in up to these amounts.
- the total content of stearidonic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of eicosatetraenoic acid is up to 1 wt%, preferably up to 0.75 wt%, more preferably up to 0.5 wt %.
- the composition comprises an amount of eicosatetraenoic acid in up to these amounts.
- the total content of eicosatetraenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of eicosatetraenoic acid is up to 0.5 wt%, preferably up to 0.475 wt%, more preferably up to 0.46 wt %.
- the composition comprises an amount of eicosatetraenoic acid in up to these amounts.
- the total content of eicosatetraenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of docosapentaenoic acid is up to 1 wt%, preferably up to 0.6 wt%, more preferably up to 0.3 wt %.
- the composition comprises an amount of docosapentaenoic acid in up to these amounts.
- the total content of docosapentaenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of docosapentaenoic acid is up to 0.4 wt%, preferably up to 0.35 wt%, more preferably up to 0.33 wt %.
- the composition comprises an amount of docosapentaenoic acid in up to these amounts.
- the total content of docosapentaenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the composition preferably comprises greater than 96.5 wt% EPA, up to 1 wt% DHA. up to 1 wt% a-linolenic acid, up to 1 wt% stearidonic acid, up to 1 wt% eicosatetraenoic acid, up to 1 wt% docosapentaenoic acid, and up to 0.25 wt% arachidonic acid.
- the composition preferably comprises greater than 96.5 wt% EPA, up to 0.2 wt% DHA, up to 0.3 wt% a-linolenic acid, up to 0.4 wt% steandonic acid, up to 0.5 wt% eicosatetraenoic acid, up to 0.35 wt% docosapentaenoic acid, and up to 0.25 wt% arachidonic acid.
- the composition more preferably comprises from 96.5 to 99 wt% EPA, up to 0.6 wt% DHA, up to 0.6 wt% ⁇ -linolenic acid, from 0.15 to 0.6 wt% stearidonic acid, from 0.1 to 0.75 wt% eicosatetraenoic acid, up to 0.6 wt% docosapentaenoic acid, and up to 0.6 wt% arachidonic acid.
- the composition more preferably comprises from 96.5 to 99 wt% EPA, up to 0.2 wt% DHA, up to 0.3 wt% ⁇ -linolenic acid, from 0.15 to 0.4 wt% stearidonic acid, from 0.1 to 0.5 wt% eicosatetraenoic acid, up to 0.35 wt% docosapentaenoic acid, and up to 0.25 wt% arachidonic acid.
- the composition most preferably comprises from 98 to 99 wt% EPA, from 0.1 to 0.3 wt% DHA, from 0.3 to 0.35 wt% stearidonic acid, from 0.1 to 0.3 wt% eicosatetraenoic acid, and from 0.3 to 0.35 wt% docosapentaenoic acid.
- the composition most preferably comprises from 96.5 to 99 wt% EPA, from 0.1 to 0.5 wt% DHA, from 0.1 to 0.5 wt% stearidonic acid, from 0.1 to 0.5 wt% eicosatetraenoic acid, from 0.1 to 0.5 wt% docosapentaenoic acid, and from 0.1 to 0.3 wt% arachidonic acid.
- the composition most preferably comprises from 98 to 99 wt% EPA, from 0.1 to 0.2 wt% DHA, from 0.3 to 0.35 wt% stearidonic acid, from 0.1 to 0.2 wt% eicosatetraenoic acid, and from 0.3 to 0.35 wt% docosapentaenoic acid.
- the composition most preferably comprises from 96.5 to 97.5 wt% EPA, from 0.25 to 0.35 wt% ⁇ -linolenic acid, from 0.18 to 0.24 wt% stearidonic acid, from 0.4 to 0.46 wt% eicosatetraenoic acid, and from 0.15 to 0.25 wt% arachidonic acid.
- the content of isomeric impurities is up to 1.5 wt%.
- the content of isomeric impurities is up to 1 wt%, preferably up to 0.5 wt%, more preferably up to 0.25 wt%, even more preferably up to 0.25 wt%, and most preferably up to 0.1 wt%.
- the present invention also provides a composition
- PUFA product comprising a PUFA product, wherein the PUFA product is a mixture of EPA and DHA, wherein (i) the total content of EPA and DHA is 80 wt% or greater, (ii) the content of EPA is from 41 to 60 wt% and the content of DHA is from 16 to 48 wt%, and (iii) the total content of ⁇ -3 polyunsaturated fatty acids is 94 wt% or greater and/or the total content of ⁇ -6 polyunsaturated fatty acids is up to 4 wt%.
- the PUFA product is a mixture of EPA and DHA, wherein (i) the total content of EPA and DHA is 80 wt% or greater, (ii) the content of EPA is from 41 to 60 wt% and the content of DHA is from 16 to 48 wt%, and (iii) the total content of ⁇ -3 polyunsaturated fatty acids is 94 wt% or greater and/or the
- the PUFA product, ⁇ -3 and ⁇ -6 PUFAs are optionally in the form of their alkyl esters, typically ethyl esters.
- the EPA/DHA PUFA product is in the form of its ethyl esters.
- the composition is typically a composition comprising a PUFA product, wherein the PUFA product is a mixture of EPA and DHA, wherein (i) the total content of EPA and DHA is 80 wt% or greater, (ii) the content of EPA is from 41 to 60 wt% and the content of DHA is from 16 to 48 wt%, and (iii) the total content of ⁇ -3 polyunsaturated fatty acids is 94 wt% or greater.
- the PUFA product is a mixture of EPA and DHA, wherein (i) the total content of EPA and DHA is 80 wt% or greater, (ii) the content of EPA is from 41 to 60 wt% and the content of DHA is from 16 to 48 wt%, and (iii) the total content of ⁇ -3 polyunsaturated fatty acids is 94 wt% or greater.
- composition is a composition
- PUFA product comprising a PUFA product, wherein the PUFA product is a mixture of EPA and DHA, wherein (i) the total content of EPA and DHA is 80 wt% or greater, (ii) the content of EPA is from 41 to 60 wt% and the content of DHA is from 16 to 48 wt%, and (iii) the total content of ⁇ -6 polyunsaturated fatty acids is up to 4 wt%.
- the total content of EPA and DHA is 82 wt% or greater, preferably 83 wt% or greater, more preferably 84 wt% or greater, even more preferably 85 wt% or greater, and most preferably 86 wt% or greater.
- the content of EPA is from 41 to 60 wt%, preferably from 45 to 60 wt%, more preferably from 47 to 60 wt%, even more preferably from 47 to 57 wt%, and most preferably from 50 to 55 wt%.
- the content of DHA is from 16 to 48 wt%, preferably from 20 to 45 wt%, more preferably from 25 to 42 wt%, even more preferably from 28 to 38 wt%, and most preferably from 30 to 35 wt%.
- the total content of co-3 polyunsaturated fatty acids is 94 wt% or greater, preferably 95 wt% or greater, more preferably 96 wt% or greater, and most preferably 97 wt% or greater.
- the total content of a-linolenic acid is up to 0.4 wt%, preferably up to 0.35 wt%, more preferably up to 0.31 wt %.
- the composition comprises an amount of a-linolenic acid in up to these amounts.
- the total content of ⁇ -linolenic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater, more preferably 0.2 wt% or greater, and even preferably from 0.2 to 0.4 wt%.
- the total content of stearidonic acid is up to 1.9 wt%, preferably up to 1.5 t%, more preferably up to 1.25 wt %.
- the composition comprises an amount of stearidonic acid in up to these amounts.
- the total content of stearidonic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of eicosatetraenoic acid is up to 2.0 wt%, preferably up to 1.9 wt%.
- the composition comprises an amount of eicosatetraenoic acid in up to these amounts.
- the total content of eicosatetraenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater, more preferably 1.0 wt% or greater, and even more preferably from 1.0 to 1.9 wt%.
- the total content of eicosapentaenoic acid is up to 3.0 wt%, preferably up to 2.75 wt%.
- the composition comprises an amount of eicosapentaenoic acid in up to these amounts.
- the total content of eicosapentaenoic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater, more preferably 2 wt% or greater, and even more preferably from 2 to 2.75 wt%.
- the total content of docosapentaenoic acid is up to 6 wt%, preferably up to 5.5 wt%, more preferably up to 5.25 wt %.
- the composition comprises an amount of docosapentaenoic acid in up to these amounts.
- the total content of docosapentaenoic acid is 0.05 wt% or greater, preferably 0.1 wt % or greater, more preferably 4 wt% or greater, and even more preferably from 4 to 5.25 wt%.
- the total content of ⁇ -6 polyunsaturated fatty acids in this further embodiment is typically up to 4 wt%.
- the composition comprises an amount of co-6 polyunsaturated fatty acids up to these amounts.
- the total content of ⁇ -6 polyunsaturated fatty acids is up to 3.75 wt%, preferably up to 3.5 wt%, more preferably up to 3.25 wt%, even more preferably up to 3 wt%, most preferably up to 2.85 wt%.
- the total content of ⁇ -6 polyunsaturated fatty acids is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of linoleic acid is up to 0.5 wt%, preferably up to 0.4 wt%, more preferably up to 0.25 wt%.
- the composition comprises an amount of linoleic acid in up to these amounts.
- the total content of linoleic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater, more preferably 0.15 wt% or greater, and even more preferably from 0.15 to 0.25 wt%.
- the total content of gamma-linolenic acid is up to 0.19 wt%, preferably up to 0.15 wt%, more preferably up to 0.1 wt%.
- the composition comprises an amount of gamma-linolenic acid in up to these amounts.
- the total content of gamma-linolenic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of dihommo-gamma-linolenic acid is up to 0.1 wt%.
- the composition comprises an amount of dihommo-gamma-linolenic acid in up to these amounts.
- the total content of dihommo-gamma-linolenic acid is 0.05 wt% or greater.
- the total content of arachidonic acid is up to 2.5 wt%, preferably up to 2.25 wt%, more preferably up to 2.1 wt%.
- the composition comprises an amount of arachidonic acid in up to these amounts.
- the total content of arachidonic acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the total content of adrenic acid is up to 0.1 wt%.
- the composition comprises an amount of adrenic acid in up to this amount.
- the total content of adrenic acid is 0.05 wt% or greater.
- the total content of docosapentaenoic (co-6) acid is up to 0.9 wt%, preferably up to 0.75 wt%. More preferably up to 0.65 wt%.
- the composition comprises an amount of docosapentaenoic ( ⁇ -6) acid in up to these amounts.
- the total content of docosapentaenoic ( ⁇ -6) acid is 0.05 wt% or greater, preferably 0.1 wt% or greater.
- the composition preferably comprises from 50 to 55 wt% EPA, from 30 to 35 wt% DHA, up to 0.4 wt % a-linolenic acid, up to 1.25 wt % stearidonic acid, up to 1.9 wt% eicosatetraenoic acid, up to 2.75 wt%
- eicosapentaenoic acid up to 5.25 wt % docosapentaenoic acid, up to 0.25 wt% linoleic acid, up to 0.1 wt% gamma-linolenic acid, up to 0.1 wt% dihommo-gamma- linolenic acid, up to 2.1 wt% arachidonic acid, up to 0.1 wt% adrenic acid, and up to 0.75 wt% docosapentaenoic ( ⁇ -6) acid.
- the composition more preferably comprises from 50 to 55 wt% EPA, from 30 to 35 wt% DHA, from 0.2 to 0.4 wt% a-linolenic acid, up to 1.25 wt % stearidonic acid, from 1.0 to 1.9 wt% eicosatetraenoic acid, from 2 to 2.75 wt% eicosapentaenoic acid, from 4 to 5.25 wt% docosapentaenoic acid, from 0.15 to 0.25 wt% linoleic acid, up to 0.1 wt% gamma-linolenic acid, up to 0.1 wt% dihommo- gamma-linolenic acid, up to 2.1 wt% arachidonic acid, up to 0.1 wt% adrenic acid, and up to 0.75 wt% docosapentaenoic ( ⁇ -6) acid.
- the content of isomeric impurities is up to 1.5 wt%.
- the content of isomeric impurities is up to 1 wt%, preferably up to 0.5 wt%, more preferably up to 0.25 wt%, even more preferably up to 0.25 wt%, and most preferably up to 0.1 wt%.
- the inventors have also surprisingly found that oils can be produced with a reduced amount of environmental pollutants, compared with known oils.
- the present invention also provides a composition comprising a PUFA product, as defined herein, wherein (a) the total amount of polyaromatic hydrocarbons in the composition is up to 0.89 ⁇ g/kg, (b) the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlonnated dibenzofurans is up to 0.35 pg/g (c) the total amount of polychlonnated biphenyls is up to 0.0035 mg/kg, and/or (d) the total amount of dioxins, furans, dibenzeno-para-dioxins, polychlorinated
- the present invention provides a composition comprising a PUFA product, as defined herein, wherein (a) the total amount of polyaromatic hydrocarbons in the composition is up to 0.89 ⁇ g/kg, (b) the total amount of dioxins, furans, dibenzeno- para-dioxins and polychlorinated dibenzofurans is up to 0.35 pg/g, and/or (d) the total amount of dioxins, furans and dioxin-like polychlorinated biphenyls is up to 1 pg g.
- the total amount of polyaromatic hydrocarbons in this still further embodiment in the composition is up to 0.89 ⁇ g/kg.
- the composition comprises an amount of polyaromatic hydrocarbons up to this amount.
- the total amount of polyaromatic hydrocarbons in the composition is up to 0.85 ⁇ g/kg, preferably up to 0.8 ⁇ g/kg, more preferably up to 0.7 g/kg, even more preferably up to 0.6 ⁇ g/kg, still more preferably up to 0.5 ⁇ g/kg, yet more preferably up to 0.4 ⁇ g/kg, yet more preferably up to 0.3 g/kg, yet more preferably up to 0.2 ⁇ g/kg, yet more preferably up to 0.1 ⁇ g/kg, and most preferably up to 0.05 ⁇ g/kg.
- Typical polyaromatic hydrocarbons are well known to one skilled in the art and include acenaphthene, acenaphthylene, anthracene, benz[a] anthrac
- the amounts referred to above refer to the content of benzo [a] pyrene.
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans in this still further embodiment is up to 0.35 pg/g.
- the composition comprises an amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans up to this amount.
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans is up to 0.325 pg/g, preferably up to 0.3 pg/g, more preferably up to 0.275 pg g, even more preferably up to 0.25 pg/g, still more preferably up to 0.225 pg/g, yet more preferably up to 0.2 pg/g, and most preferably up to 0.185 pg/g.
- WHO World Health Organization
- TEZ World Health Organization
- PCDDs dibenzeno-para-dioxins
- PCDFs polychlorinated dibenzofurans
- PCDDs Dibenzo-p-dioxins
- PCBs Dioxin-like PCBs: Non-ortho PCBs
- PCDFs Dibenzofurans
- the quantity of PCDDs, PCDFs and Dioxin-like PCBs is determined according to the method set out in Community regulations (EC) No. 1881/2006 and 1883/2006.
- the total amount of polychlorinated biphenyls in this still further embodiment is up to 0.0035 mg/kg.
- the composition comprises an amount of
- polychlorinated biphenyls up to this amount.
- the total amount of polychlorinated biphenyls is up to 0.003 mg/kg, preferably up to 0.0025 mg/kg, more preferably up to 0.002 mg/kg, even more preferably up to 0.0015 mg/kg, still more preferably up to 0.001 mg/kg, yet more preferably up to 0.00075 mg/kg, and most preferably up to 0.0007 mg kg.
- PCBs Polychlorobiphenyls
- PCBs Polychlorobiphenyls
- the total amount of dioxins, furans, dibenzeno-para-dioxins, polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls in this still further embodiment is up to 1 pg/g.
- the composition comprises an amount of dioxins, furans, dibenzeno-para-dioxins, polychlorinated dibenzofurans and dioxin- like polychlorinated biphenyls in up to this amount.
- the total amount of dioxins, furans, dibenzeno-para-dioxins, polychlorinated dibenzofurans and dioxin- like polychlorinated biphenyls is up to 0.75 pg/g, preferably up to 0.5 pg/g, more preferably up to 0.45 pg g, even more preferably up to 0.4 pg/g, still more preferably up to 0.35 pg/g, and most preferably up to 0.3 pg/g.
- Dioxins, furans, dibenzeno-para-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls are well known to the skilled person. Typically, these are as defined in Community regulation (EC) No. 1881/2006 and 1883/2006 the entirety of which is incorporated herein by reference.
- PCDDs, PCDFs and Dioxin-like PCBs defined in Community regulation (EC) No. 1881/2006 and 1883/2006 together with their TEF values are as defined above.
- the total amount of polyaromatic hydrocarbons in the composition is up to 0.05 ⁇ g kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans is up to 0.2 pg/g
- the total amount of polychlorinated biphenyls is up to 0.0015 mg/kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls is up to 0.3 pg/g.
- the total amount of polyaromatic hydrocarbons in the composition is up to 0.05 ⁇ g kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans is up to 0.2 pg/g and/or (d) the total amount of dioxins, furans, dibenzeno-para-dioxins and
- polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls is up to 0.3 pg/g-
- the total amount of polyaromatic hydrocarbons in the composition is up to 0.05 ⁇ g kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans is up to 0.2 pg/g
- the total amount of polychlorinated biphenyls is up to 0.0015 mg/kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls is up to 0.3 pg/g.
- the total amount of polyaromatic hydrocarbons in the composition is up to 0.05 ⁇ g/kg
- the total amount of dioxins, furans, dibenzeno-para-dioxins and polychlorinated dibenzofurans is up to 0.2 pg/g
- polychlorinated dibenzofurans and dioxin-like polychlorinated biphenyls is up to 0.3 pg/g.
- the content of isomeric impurities is up to 1.5 wt%.
- the content of isomeric impurities is up to 1 wt%, preferably up to 0.5 wt%, more preferably up to 0.25 wt%, even more preferably up to 0.25 wt%, and most preferably up to 0.1 wt%.
- the inventors have also found that oils of high purity can be produced which avoid the problems of isomerization, peroxidation and oligomerization associated with distilled oils.
- the quantity of isomeric impurities present in a PUFA product of the present invention will depend on the amount of isomeric impurities present in the feed mixture.
- the amount of isomeric impurities is not increased by the process of the present invention, unlike distillation.
- the limit of the content of isomers in the PUFA product is the isomeric content of the starting material. If the starting material has no isomers present, then the resultant PUFA product will also be substantially free of isomers. This advantage is not observed in distillation.
- the chromatographic separation process of the present invention does not substantially increase the amount of isomeric impurities in the PUFA product relative to the amount of isomeric impurities present in the feed mixture.
- substantially increase is typically understood to mean increase by 10 wt% or less, preferably 5 wt% or less, more preferably 3 wt% or less, even more preferably 1 wt% or less, yet more preferably 0.5 wt% or less, and most preferably 0.1 wt% or less.
- the present invention also provides a composition comprising a PUFA product, wherein the content of isomeric impurities is up to 1.5 wt%.
- the composition contains an amount of isomeric impurities up to this amount.
- the content of isomeric impurities is up to 1 wt%, preferably up to 0.5 wt%, more preferably up to 0.25 wt%, and most preferably up to 0.1 wt%.
- the PUFA product is DHA, optionally in the form of its ethyl ester.
- the composition comprises greater than 85 wt% PUFA product, preferably greater than 90 wt%, more preferably greater than 92.5 wt%, most preferably greater than 95 wt %.
- the composition contain comprises greater than 85 wt% DHA, optionally in the form of its ethyl ester, preferably greater than 90 wt%, more preferably greater than 92.5 wt%, most preferably greater than 95 wt %.
- the composition typically comprises as PUFA product DHA, optionally in the form of its ethyl ester, in an amount greater than 95 wt%, wherein the content of isomeric impurities is up to 1 wt%, preferably up to 0.5 wt%, more preferably up to 0.25 wt%, and most preferably up to 0.1 wt%
- DHA PUFA product DHA
- the improved process of the invention allows much higher purities of PUFA product to be achieved efficiently, as both the more and less polar impurities can be removed in a single process.
- the PUFA product of the present invention typically has a purity of greater than 80 weight%, preferably greater than 85 weight%, more preferably greater than 90 weight%, even more preferably greater than 95 weight %, yet more preferably greater than 97 weight%, and most preferably greater than 99 weight%.
- concentrations above refer to the concentration of that PUFA or derivative.
- concentrations above refer to the combined concentration of the PUFAs, or derivatives thereof.
- the method of the present invention also avoids the problems of isomerization, peroxidation and oligomerization associated with distilled oils.
- the PUFA product of the present invention typically has a content of isomeric impurities of less than 5 weight%, preferably less than 3 weight%, and more preferably less than 1 weight%.
- the isomeric impurities include PUFA isomers, peroxidation and oligomerization products.
- PUFA isomers include positional and/or geometric isomers. Examples of positional and/or geometric isomers of EPA include 17E-EPA, 5E-EPA, 5E,8E-EPA, 8E,1 1E-EPA, 5E,14E-EPA, and 5E,8E,1 1E.17E-EPA.
- the process of the present invention will generally be controlled by a computer.
- the present invention therefore also provides a computer program for controlling a chromatographic apparatus as defined herein, the computer program containing code means that when executed instruct the apparatus to carry out the process of the invention.
- Example 1 A fish oil derived feedstock (55weight% EPA EE, 5 weight% DHA EE) is fractionated using an actual moving bed chromatography system using bonded CI 8 silica gel (particle size 300 ⁇ ) as stationary phase and aqueous methanol as eluent according to the system schematically illustrated in Figure 8. 15 columns (diameter: 76.29mm, length: 914.40mm) are connected in series as shown in Figure 8.
- EPA EE is produced at a high level of purity (85 to 98% by GC FAMES).
- GC FAMES traces of the zone 1 extract and raffinate, and of the zone 2 extract and raffinate are shown as Figures 1 1 and 12 respectively.
- Feedstock (F) feed rate 70 ml/min
- Feedstock (F) feed rate 210 ml/min
- Feedstock (F) feed rate 25 ml/min
- Desorbent feed rate (Dl) in first zone 2050 ml/min
- Desorbent feed rate (D2) in second zone 1700 ml/min
- Feedstock (F) feed rate 50 ml/min
- Desorbent feed rate (Dl) in first zone 4125 ml/min
- Desorbent feed rate (D2) in second zone 3375 ml/min
- Extract container accumulation rate (E2) in second zone 1800 ml/min
- Feedstock (F) feed rate 50 ml/min
- Desorbent feed rate (Dl) in first zone 4000 ml/min
- Desorbent feed rate (D2) in second zone 3200 ml/min
- Feedstock (F) feed rate 100 ml/min
- Desorbent feed rate (Dl) in first zone 4050 ml/min
- Desorbent feed rate (D2) in second zone 3300 ml/min
- Feedstock (F) feed rate 25 ml/min
- Desorbent feed rate (Dl) in first zone 1275 ml/min
- Extract container accumulation rate (El) in first zone 750 ml/min
- Desorbent feed rate (D2) in second zone 1275 ml/min
- Feedstock (F) feed rate 50 ml/min
- Desorbent feed rate (Dl) in first zone 2550 ml/min
- Desorbent feed rate (D2) in second zone 2000 ml/min
- Extract recycle rate (D2-E2) in second zone 600 ml/min
- a fish oil derived feedstock comprising eicosatetraenoic acid ethyl ester (ETA EE), EPA EE, isomers thereof and DHA EE was fractionated using an actual moving bed chromatography system using bonded C 18 silica gel (particle size 40-60 ⁇ ) as stationary phase and aqueous methanol as eluent according to the system
- Feedstock (F) feed rate 0.5 ml/min
- Extract (El) rate from the first zone 1.9 ml/min
- EPA EE was produced at a high level of purity (greater than 90 weight%, greater than 95 weight%, greater than 98 weight%).
- a fish oil derived feedstock (55weight% EPA EE, 5 weight% DHA EE) was fractionated using an actual moving bed chromatography system using bonded C 18 silica gel (particle size 300 ⁇ , particle porosity 150 angstroms) as stationary phase and aqueous methanol as eluent according to the system schematically illustrated in Figure 8. 15 columns (diameter: 10 mm, length: 250 mm) are connected in series as shown in Figure 8.
- Feedstock (F) feed rate 0.5 ml/min
- Extract (El) rate from the first zone 4 ml/min
- Extract (E2) rate from the second zone 4.1 ml/min
- a fish oil derived feedstock (70weight% DHA EE, 7 weight% EPA EE) is fractionated using an actual moving bed chromatography system using bonded CI 8 silica gel (particle size 300 ⁇ ) as stationary phase and aqueous methanol as eluent according to the system schematically illustrated in Figure 8. 15 columns (diameter: 76.29mm, length: 914.40mm) are connected in series as shown in Figure 8.
- Feedstock (F) feed rate 25 ml/min
- Desorbent feed rate (Dl) in first zone 2062.5 ml/min
- Extract rate (El) in first zone 900 ml/min
- Desorbent feed rate (D2) in second zone 1500 ml/min
- Extract rate (E2) in second zone 450 ml/min
- DHA EE is produced at a high level of purity (>97% by GC FAMES).
- a GC FAMES trace of the zone 2 extract is shown as Figure 14.
- a fish oil derived feedstock (33 weight% EPA EE, 22 weight% DHA EE) is fractionated using an actual moving bed chromatography system using bonded CI 8 silica gel (particle size 300 ⁇ ) as stationary phase and aqueous methanol as eluent according to the system schematically illustrated in Figure 8. 15 columns (diameter: 76.29mm, length: 914.40mm) are connected in series as shown in Figure 8.
- Feedstock (F) feed rate 40 ml/min
- Extract rate (El) in first zone 825 ml/min
- Desorbent feed rate (D2) in second zone 1425 ml/min
- Extract rate (E2) in second zone 787.5 ml/min
- a mixture of EPA EE and DHA EE is produced at a high level of purity (>80% total EPA EE and DHA EE).
- Dioxin limits include the sum of polychlorinated dibenzeno-para-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) and expressed in World Health Organisation (WHO) toxic equivalents using WHO-toxic equivalent factors (TEFs). This means that analytical results relating to 17 individual dioxin congeners of toxicological concern are expressed in a single quantifiable unit: TCDD toxic equivalent concentration or TEQ
- a GC trace of the DHA-rich oil prepared in accordance with the invention is shown as Figure 14. There is no evidence of isomeric impurities in the GC trace.
- a GC trace of the oil prepared by distillation is shown as Figure 15. The four peaks with longer elution times than the DHA peak correspond to DHA isomers. From the GC trace it can be seen that the oil prepared by distillation contains about 1.5 wt% of isomeric impurities.
- esters esters 1 )
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Sustainable Development (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201080064359.5A CN102811781B (en) | 2009-12-30 | 2010-12-24 | Simulated Moving Bed Chromatographic Separation Process For Recovering Polyunsaturated Fatty Acid |
CA2785742A CA2785742C (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process |
KR1020127020135A KR101761959B1 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids |
BR112012016308-6A BR112012016308B1 (en) | 2009-12-30 | 2010-12-24 | CHROMATOGRAPHIC SEPARATION PROCESS TO RECOVER A POLY-INSATURATED FATTY ACID (PUFA) PRODUCT AND COMPOSITION |
ES10818131.4T ES2459951T3 (en) | 2009-12-30 | 2010-12-24 | Simulated mobile bed chromatographic separation process for the purification of polyunsaturated fatty acids |
DK10818131.4T DK2519332T3 (en) | 2009-12-30 | 2010-12-24 | CHROMATOGRAPHIC SEPARATION PROCEDURE WITH SIMULATED MOVING BED TO CLEAN MULTI-Saturated FAT ACIDS |
US13/519,618 US9321715B2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process |
AU2010338031A AU2010338031B2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids |
PL10818131T PL2519332T3 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids |
JP2012546499A JP5872483B2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatograph separation method |
EP20208062.8A EP3865469A3 (en) | 2009-12-30 | 2010-12-24 | Polyunsaturated fatty acid compositions obtainable by a simulated moving bed chromatographic separation process |
EP13154052.8A EP2591778B1 (en) | 2009-12-30 | 2010-12-24 | Polyunsaturated fatty acid compositions obtainable by a simulated moving bed chromatographic separation process |
EP10818131.4A EP2519332B1 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids |
KR1020177020219A KR101801011B1 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process for the purification of polyunsaturated fatty acids |
RU2012131913/05A RU2538981C2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation method |
US14/870,873 US9790162B2 (en) | 2009-12-30 | 2015-09-30 | Simulated moving bed chromatographic separation process |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29118409P | 2009-12-30 | 2009-12-30 | |
GB0922707.5 | 2009-12-30 | ||
GB0922707A GB0922707D0 (en) | 2009-12-30 | 2009-12-30 | New process |
US61/291,184 | 2009-12-30 | ||
GBGB1015343.5A GB201015343D0 (en) | 2010-09-14 | 2010-09-14 | New process |
GB1015343.5 | 2010-09-14 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/519,618 A-371-Of-International US9321715B2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process |
US14/870,873 Division US9790162B2 (en) | 2009-12-30 | 2015-09-30 | Simulated moving bed chromatographic separation process |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011080503A2 true WO2011080503A2 (en) | 2011-07-07 |
WO2011080503A3 WO2011080503A3 (en) | 2011-08-25 |
Family
ID=44246942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2010/002339 WO2011080503A2 (en) | 2009-12-30 | 2010-12-24 | Simulated moving bed chromatographic separation process |
Country Status (15)
Country | Link |
---|---|
US (2) | US9321715B2 (en) |
EP (3) | EP3865469A3 (en) |
JP (6) | JP5872483B2 (en) |
KR (2) | KR101761959B1 (en) |
CN (2) | CN102811781B (en) |
AU (1) | AU2010338031B2 (en) |
BR (1) | BR112012016308B1 (en) |
CA (3) | CA2785742C (en) |
DK (1) | DK2519332T3 (en) |
ES (2) | ES2862980T3 (en) |
PE (1) | PE20130491A1 (en) |
PL (1) | PL2519332T3 (en) |
PT (1) | PT2519332E (en) |
RU (2) | RU2538981C2 (en) |
WO (1) | WO2011080503A2 (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012109545A2 (en) | 2011-02-11 | 2012-08-16 | E. I. Du Pont De Nemours And Company | Method for obtaining a lipid-containing composition from microbial biomass |
WO2013005047A1 (en) * | 2011-07-06 | 2013-01-10 | Basf Pharma (Callanish) Limited | Heated chromatographic separation process |
WO2013083482A1 (en) * | 2011-12-05 | 2013-06-13 | Chromacon Ag | Chromatographic method for the separation of fatty acid mixtures |
WO2013102800A1 (en) | 2012-01-04 | 2013-07-11 | Naturalis S.A. | Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil |
WO2013172346A1 (en) * | 2012-05-14 | 2013-11-21 | 日本水産株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
WO2013177056A1 (en) * | 2012-05-23 | 2013-11-28 | Orochem Technologies, Inc. | Process and adsorbent for separating ethanol and associated oxygenates from a biofermentation system |
EP2732014A1 (en) | 2011-07-14 | 2014-05-21 | Soluciones Extractivas Alimentarias, S.L. | New process for reducing pollutants in fats and oils and their derivatives |
JP2014528907A (en) * | 2011-06-16 | 2014-10-30 | イエフペ エネルジ ヌヴェルIfp Energies Nouvelles | Method and apparatus for pseudo-countercurrent chromatographic separation with low pressure drop and high zone bed number |
EP2801604A1 (en) | 2013-05-07 | 2014-11-12 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
WO2014180654A1 (en) | 2013-05-07 | 2014-11-13 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
EP2883860A1 (en) | 2013-12-11 | 2015-06-17 | Novasep Process | Chromatographic method for producing polyunsaturated fatty acids |
WO2015086591A1 (en) | 2013-12-11 | 2015-06-18 | Novasep Process | Purification of fatty acids by a chromatographic method |
WO2015086607A1 (en) | 2013-12-11 | 2015-06-18 | Novasep Process | Method for chromatographic purification of a fatty acid |
US9234157B2 (en) | 2011-07-06 | 2016-01-12 | Basf Pharma Callanish Limited | SMB process |
US9260677B2 (en) | 2011-07-06 | 2016-02-16 | Basf Pharma Callanish Limited | SMB process |
US9315762B2 (en) | 2011-07-06 | 2016-04-19 | Basf Pharma Callanish Limited | SMB process for producing highly pure EPA from fish oil |
JP2016513452A (en) * | 2013-03-07 | 2016-05-16 | アルジシス,エルエルシー | Production of omega-3 fatty acids from phytium species |
US9370730B2 (en) | 2011-07-06 | 2016-06-21 | Basf Pharma Callanish Limited | SMB process |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
WO2016207734A1 (en) * | 2015-06-26 | 2016-12-29 | Pronova Biopharma Norge As | Composition for treatment of nafld |
US9629820B2 (en) | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
JP2017094323A (en) * | 2013-01-09 | 2017-06-01 | バスフ ファーマ(カラニッシュ)リミテッド | Multi-step separation method |
US9790162B2 (en) | 2009-12-30 | 2017-10-17 | Basf Pharma (Callanish) Limited | Simulated moving bed chromatographic separation process |
US10123986B2 (en) | 2012-12-24 | 2018-11-13 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10864185B2 (en) | 2014-09-17 | 2020-12-15 | Nippon Suisan Kaisha, Ltd. | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same |
US10975031B2 (en) | 2014-01-07 | 2021-04-13 | Novasep Process | Method for purifying aromatic amino acids |
US11330817B2 (en) | 2013-12-04 | 2022-05-17 | Nippon Suisan Kaisha, Ltd. | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil |
WO2023111317A1 (en) | 2021-12-17 | 2023-06-22 | Basf Se | Chromatographic separation process for efficient purification of polyunsaturated fatty acids |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102936534A (en) * | 2012-12-07 | 2013-02-20 | 江南大学 | Process for simultaneously extracting phosphatide, gossypol and pigments from cottonseed oil |
US8802880B1 (en) | 2013-05-07 | 2014-08-12 | Group Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
WO2015015716A1 (en) | 2013-07-31 | 2015-02-05 | 備前化成株式会社 | Method for separating fat-soluble material by simulated moving bed chromatography, and device for same |
US9163198B2 (en) * | 2014-01-17 | 2015-10-20 | Orochem Technologies, Inc. | Process for purification of EPA (eicosapentanoic acid) ethyl ester from fish oil |
CN105272844B (en) * | 2014-06-09 | 2017-05-17 | 河北海德生物科技有限公司 | Method for purifying high-purity fish oil EPA(eicosapentaenoic acid) ethyl ester and DHA(docosahexaenoic acid) ethyl ester |
CN104529772B (en) * | 2014-12-17 | 2016-12-07 | 浙江大学 | A kind of simulated moving bed chromatography prepares high-purity EPA ester and the method for DHA ester monomer |
US9546125B2 (en) * | 2015-02-11 | 2017-01-17 | Orochem Technologies, Inc. | Continuous process for extraction of unsaturated triglycerides from fish oil |
US20160297747A1 (en) | 2015-04-08 | 2016-10-13 | Invista North America S.A.R.L. | Materials and methods for the selective recovery of monovalent products from aqueous solutions using continuous ion exchange |
US10343084B2 (en) | 2015-04-10 | 2019-07-09 | Invista North America S.A.R.L. | Process for separation of diamines and/or omega-aminoacids from a feed mixture |
CA3001018A1 (en) * | 2015-10-05 | 2017-04-13 | Dsm Ip Assets B.V. | Oil compositions and methods of making |
TWI578985B (en) * | 2016-05-02 | 2017-04-21 | Extraction and purification of conjugated triene linoleic acid (CLN) | |
TWI635075B (en) * | 2017-03-24 | 2018-09-11 | 義守大學 | Method of purifying conjugated linolenic acid |
CN108728247A (en) * | 2017-04-13 | 2018-11-02 | 义守大学 | The method of purified conjugate linolenic acid |
TWI648258B (en) * | 2017-07-10 | 2019-01-21 | 喬璞科技有限公司 | Mothod of purifying polyunsaturated fatty acid and eicosapentaenoic acid |
TWI648393B (en) * | 2017-08-15 | 2019-01-21 | 喬璞科技有限公司 | Method for purifying unsaturated fatty acid and purifying linolenic acid |
CN107556187A (en) * | 2017-08-31 | 2018-01-09 | 江苏科技大学 | Beta cyclodextrin embedding combined simulation mobile bed chromatic partition method prepares the linolenic method of high-purity alpha |
EP3586640A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
CN109589644B (en) * | 2018-12-25 | 2021-01-22 | 杭州奕安济世生物药业有限公司 | Chromatographic column of reduced model and preparation method thereof |
CN112592268B (en) * | 2020-12-18 | 2022-12-09 | 江苏汉邦科技股份有限公司 | Method for separating EPA (eicosapentaenoic acid) in fish oil by using continuous chromatographic system |
LU500093B1 (en) * | 2021-04-27 | 2022-10-31 | K D Pharma Bexbach Gmbh | Process for separating a mixture of substances |
JP2024518338A (en) * | 2021-04-27 | 2024-05-01 | カーデー・ファルマ・ベクスバッハ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Method for separating mixtures of substances |
CN114790142B (en) * | 2022-04-26 | 2024-03-15 | 江苏科技大学 | Method for separating triglyceride type alpha-linolenic acid monomer in silkworm chrysalis oil by simulated moving bed chromatography technology |
US11548864B1 (en) | 2022-06-15 | 2023-01-10 | Zaiput Flow Technologies LLC | Separation of chemical species using multiple liquid phases and related systems |
CN115073292B (en) * | 2022-07-01 | 2023-10-03 | 江苏汉邦科技股份有限公司 | Preparation method of eicosapentaenoic acid ethyl ester |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985589A (en) | 1957-05-22 | 1961-05-23 | Universal Oil Prod Co | Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets |
FR2103302A5 (en) | 1970-07-23 | 1972-04-07 | Toray Industries | |
US3696107A (en) | 1971-05-27 | 1972-10-03 | Richard W Neuzil | Improved hydrocarbon separation process |
US3706812A (en) | 1970-12-07 | 1972-12-19 | Universal Oil Prod Co | Fluid-solid contacting apparatus |
US4764276A (en) | 1984-07-30 | 1988-08-16 | Advanced Separation Technologies Incorporated | Device for continuous contacting of fluids and solids |
FR2651148A1 (en) | 1989-08-28 | 1991-03-01 | Inst Francais Du Petrole | CONTINUOUS PROCESS AND DEVICE FOR CHROMATOGRAPHIC SEPARATION OF A MIXTURE OF AT LEAST THREE CONSTITUENTS IN THREE EFFLUENTS PURIFIED BY TWO SOLVENTS. |
FR2651149A1 (en) | 1989-08-28 | 1991-03-01 | Inst Francais Du Petrole | CONTINUOUS PROCESS AND DEVICE FOR CHROMATOGRAPHIC SEPARATION OF A MIXTURE OF AT LEAST THREE CONSTITUENTS IN THREE PURIFIED EFFLUENTS USING A SINGLE SOLVENT AT TWO TEMPERATURES AND / OR AT TWO DIFFERENT PRESSURES. |
US5069883A (en) | 1989-10-20 | 1991-12-03 | Progress Water Technologies Corp. | Device for continuous contacting of liquids and solids |
EP0697034A1 (en) | 1993-04-29 | 1996-02-21 | Norsk Hydro As | Processes for chromatographic fractionation of fatty acids and their derivatives |
US6979402B1 (en) | 2003-12-19 | 2005-12-27 | Uop Llc | Miniature actual moving bed assembly |
Family Cites Families (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048111A (en) | 1975-06-12 | 1977-09-13 | Uop Inc. | Method for manufacturing an adsorbent useful for olefin separation |
US4036745A (en) | 1975-09-24 | 1977-07-19 | Uop Inc. | Process for separating normal and isoparaffins |
US4049688A (en) | 1976-08-02 | 1977-09-20 | Uop Inc. | Process for separating esters of fatty acids by selective adsorption |
US4048205A (en) | 1976-08-02 | 1977-09-13 | Uop Inc. | Process for separating an ester of a monoethanoid fatty acid |
US4313015A (en) | 1980-02-07 | 1982-01-26 | Uop Inc. | Separation process |
US4353838A (en) | 1981-02-13 | 1982-10-12 | Uop Inc. | Process for separating a monoethanoid fatty acid |
US4353839A (en) | 1981-02-25 | 1982-10-12 | Uop Inc. | Process for separating saturated fatty acids |
US4404145A (en) | 1981-04-10 | 1983-09-13 | Uop Inc. | Process for separating fatty acids from rosin acids |
US4329280A (en) | 1981-04-10 | 1982-05-11 | Uop Inc. | Process for separating esters of fatty and rosin acids |
US4511514A (en) | 1981-04-10 | 1985-04-16 | Uop Inc. | Process for separating oleic acid from linoleic acid |
US4522761A (en) | 1981-04-10 | 1985-06-11 | Uop Inc. | Process for separating fatty acids from rosin acids |
US4519952A (en) | 1981-04-10 | 1985-05-28 | Uop Inc. | Process for separating fatty acids from unsaponifiables |
US4524030A (en) | 1981-04-10 | 1985-06-18 | Uop Inc. | Process for separating fatty acids |
IN158368B (en) | 1981-04-10 | 1986-11-01 | Uop Inc | |
US4486618A (en) | 1981-07-30 | 1984-12-04 | Uop Inc. | Process for separating C6 olefin hydrocarbons |
JPS58109444A (en) | 1981-11-19 | 1983-06-29 | Kureha Chem Ind Co Ltd | Separation and purification of eicosapentaenoic acid or it ester and docosahexaenoic acid or its ester |
JPS5888339A (en) | 1981-11-20 | 1983-05-26 | Kagakuhin Kensa Kyokai | Separating and purifying method of eicosapentaenoic acid or ester thereof and docosahexaenoic acid or ester thereof |
JPS5888339U (en) | 1981-12-10 | 1983-06-15 | 株式会社 カネノ製作所 | Item storage device with opaque sheet |
JPS58109444U (en) | 1982-01-20 | 1983-07-26 | ミサワホ−ム株式会社 | Dust collection device |
US4560675A (en) | 1982-08-13 | 1985-12-24 | Uop Inc. | Adsorbent for separating fatty acids from rosin acids |
US4495106A (en) | 1982-08-13 | 1985-01-22 | Uop Inc. | Adsorbent and process for separating fatty acids from rosin acids |
US4521343A (en) | 1983-02-04 | 1985-06-04 | Uop Inc. | Process for separating fatty acids from rosin acids with phosphorus modified alumina molecular sieve |
US4433195A (en) | 1983-03-02 | 1984-02-21 | Uop Inc. | Separation of trans- and cis-olefins |
US4524049A (en) | 1983-08-31 | 1985-06-18 | Zimpro Inc. | Process for concurrent steam generation and metal recovery |
US4524029A (en) | 1983-09-22 | 1985-06-18 | Uop Inc. | Process for separating fatty acids |
JPS60208940A (en) | 1984-03-31 | 1985-10-21 | Nippon Zeon Co Ltd | Separation and purification of long-chain saturated acid |
JPS6137752A (en) * | 1984-07-30 | 1986-02-22 | Kuraray Co Ltd | Separation and purification of highly unsaturated long-chain fatty acid or its ester |
JPS61192797A (en) | 1985-02-21 | 1986-08-27 | 日本油脂株式会社 | Concentration of highly unsaturated acid |
US4605783A (en) | 1985-03-21 | 1986-08-12 | Uop Inc. | Process for separating monoterpenes |
JPH0317755Y2 (en) | 1985-05-24 | 1991-04-15 | ||
NO157302C (en) | 1985-12-19 | 1988-02-24 | Norsk Hydro As | PROCEDURE FOR THE PREPARATION OF A FISH OIL CONCENTRATE. |
JPS6388159A (en) * | 1986-09-30 | 1988-04-19 | Nippon Oil & Fats Co Ltd | Production of docosahexaenoic acid ester |
JPS6388159U (en) | 1986-11-27 | 1988-06-08 | ||
US5068419A (en) | 1986-12-18 | 1991-11-26 | Uop | Separation of an organic acid from a fermentation broth with an anionic polymeric adsorbent |
US4720579A (en) | 1986-12-18 | 1988-01-19 | Uop Inc. | Separation of citric acid from fermentation broth with a neutral polymeric adsorbent |
US4882065A (en) | 1987-12-11 | 1989-11-21 | Uop | Purification of sterols with activated carbon as adsorbent and chlorobenzene as desorbent |
NO163139C (en) * | 1988-01-22 | 1990-04-11 | Norsk Hydro As | PROCEDURE FOR THE PREPARATION OF N-3 MULTI-FATED ACIDS AND THEIR DERIVATIVES, SPECIFICALLY LOWER ALKYL ESTERS FROM EARLY UPCONCENTED FOOD. |
JPH0692595B2 (en) | 1988-02-01 | 1994-11-16 | 鐘淵化学工業株式会社 | Separation method of fatty acid and triglyceride |
US4961881A (en) | 1988-02-17 | 1990-10-09 | Uop | Process for separating triglycerides and regenerating absorbent used in said separation process |
JPH0225447A (en) * | 1988-07-13 | 1990-01-26 | Nippon Oil & Fats Co Ltd | Production of highly unsaturated fatty acids |
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
SU1631067A1 (en) * | 1988-09-16 | 1991-02-28 | Институт Биологии Моря Дальневосточного Отделения Ан Ссср | Method of producing docosahexaenic, eicosapentaenic and arachidonic acids or their mixture |
ZA895758B (en) | 1988-09-29 | 1990-04-25 | Fishing Ind Research I | Polyunsaturated fatty acids |
US4902829A (en) | 1988-11-16 | 1990-02-20 | Uop | Process for the adsorptive separation of hydroxy paraffinic dicarboxylic acids from olefinic dicarboxylic acids |
US5068418A (en) | 1989-05-08 | 1991-11-26 | Uop | Separation of lactic acid from fermentation broth with an anionic polymeric absorbent |
JP2895258B2 (en) * | 1990-04-24 | 1999-05-24 | ハリマ化成株式会社 | Method for selectively obtaining polyunsaturated fatty acids |
US5225580A (en) | 1990-08-16 | 1993-07-06 | Uop | Process for separating fatty acids and triglycerides |
US5179219A (en) | 1990-11-19 | 1993-01-12 | Uop | Process for separating fatty acids and triglycerides |
JPH07106281B2 (en) | 1991-01-16 | 1995-11-15 | 綜研化学株式会社 | Method and apparatus for separating and purifying multi-component mixture |
JP3400466B2 (en) * | 1991-10-28 | 2003-04-28 | 日本水産株式会社 | Method for producing high-purity eicosapentaenoic acid or ester thereof |
JP2957045B2 (en) * | 1992-04-10 | 1999-10-04 | 株式会社資生堂 | Method for separating and purifying docosahexaenoic acid or an analog thereof |
DK0592646T3 (en) | 1992-04-29 | 1999-09-20 | Inst Francais Du Petrole | Method and apparatus for fractionating a mixture in a simulated mobile bed in the presence of a compressed gas, |
JP3025590B2 (en) | 1992-10-14 | 2000-03-27 | エーザイ株式会社 | Crude purification method |
JPH07242895A (en) * | 1993-03-16 | 1995-09-19 | Ikeda Shiyotsuken Kk | Eicosapentaenoic acid of high purity and isolation and purification of lower alcohol ester thereof |
JP3340182B2 (en) | 1993-03-31 | 2002-11-05 | 雪印乳業株式会社 | Method for producing triglyceride containing docosahexaenoic acid |
JPH078268A (en) * | 1993-04-26 | 1995-01-13 | Kawasaki Steel Corp | Culture of marine microalga and production of docosahexaenoic acid thereby |
GB9404483D0 (en) | 1994-03-08 | 1994-04-20 | Norsk Hydro As | Refining marine oil compositions |
RU2127115C1 (en) * | 1994-03-28 | 1999-03-10 | Владимир Константинович Гаврисюк | Polyunsaturated fatty acid mixture "omega-3" |
JPH08100191A (en) * | 1994-09-30 | 1996-04-16 | Nisshin Flour Milling Co Ltd | Purification of highly unsaturated fatty acid or ester thereof |
JPH08218091A (en) * | 1995-02-17 | 1996-08-27 | Maruha Corp | Production of high-purity highly unsaturated fatty acid and its derivative |
EP0760393B1 (en) | 1995-08-17 | 2003-06-04 | F. Hoffmann-La Roche Ag | Chromatography process |
JPH0959206A (en) * | 1995-08-25 | 1997-03-04 | Nippon Oil & Fats Co Ltd | Production of eicosapentaenoic acid and eicosapentaenoic ester |
FR2740451B1 (en) | 1995-10-27 | 1998-01-16 | Seripharm | NOVEL INTERMEDIATES FOR THE HEMISYNTHESIS OF TAXANES, THEIR PREPARATION METHODS AND THEIR USE IN THE GENERAL SYNTHESIS OF TAXANES |
JPH09151390A (en) * | 1995-11-30 | 1997-06-10 | Bizen Kasei Kk | Purification of highly unsaturated fatty acid and its derivative |
JPH09157684A (en) | 1995-12-08 | 1997-06-17 | Chlorine Eng Corp Ltd | Purification of highly unsaturated fatty acid ester |
US5917068A (en) | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
JPH09263787A (en) * | 1996-01-26 | 1997-10-07 | Nof Corp | Production of highly unsaturated fatty acid or alkyl ester thereof |
JP3880095B2 (en) * | 1996-03-07 | 2007-02-14 | 大阪市 | Method for purifying highly unsaturated fatty acids |
JP3892497B2 (en) * | 1996-06-25 | 2007-03-14 | タマ生化学株式会社 | Method for producing eicosapentaenoic acid ester |
JPH1095744A (en) * | 1996-09-20 | 1998-04-14 | Nof Corp | Production of highly unsaturated aliphatic acid or its alkyl ester |
FR2754731B1 (en) | 1996-10-18 | 1999-07-02 | Novasep Sa | IMPROVEMENT IN METHODS FOR ENRICHING OPTICAL ISOMERS BY SIMULATED MOBILE BED |
GB9701705D0 (en) | 1997-01-28 | 1997-03-19 | Norsk Hydro As | Purifying polyunsatured fatty acid glycerides |
EP1017467B1 (en) | 1997-01-29 | 2014-07-16 | Amalgamated Research LLC | Method of displacement chromatography |
JPH10310555A (en) * | 1997-05-12 | 1998-11-24 | Y M Shii:Kk | Separation and purification of polybasic unsaturated fatty acid ester |
JPH10310556A (en) | 1997-05-12 | 1998-11-24 | Y M Shii:Kk | Separation and purification of polybasic unsaturated fatty acid ester originated from microorganism |
US6063284A (en) | 1997-05-15 | 2000-05-16 | Em Industries, Inc. | Single column closed-loop recycling with periodic intra-profile injection |
FR2764822B1 (en) | 1997-06-19 | 1999-08-13 | Novasep | METHOD FOR OPTIMIZING THE OPERATION OF A MIXTURE CONSTITUENT SEPARATION SYSTEM |
FR2766385B1 (en) | 1997-07-24 | 1999-09-03 | Novasep | METHOD FOR CONTROLLING PRESSURE IN A SIMULATED MOBILE BED SEPARATION SYSTEM |
US5840181A (en) | 1997-10-14 | 1998-11-24 | Uop Llc | Chromatographic separation of fatty acids using ultrahydrophobic silicalite |
JP3836231B2 (en) * | 1997-10-17 | 2006-10-25 | 日本化学飼料株式会社 | Highly unsaturated fatty acid-containing oil obtained from scallop midgut gland and method for producing the same |
JP2872986B1 (en) | 1998-01-21 | 1999-03-24 | 池田食研株式会社 | Purification method of lower alcohol ester of high purity highly unsaturated fatty acid |
EP1102859A1 (en) | 1998-07-22 | 2001-05-30 | Aventis Research & Technologies GmbH & Co KG | METHOD FOR OBTAINING FATTY ACIDS FROM BIOMASS BY COMBINED $i(IN-SITU) EXTRACTION, REACTION AND CHROMATOGRAPHY USING COMPRESSED GASES |
FR2781388B1 (en) | 1998-07-24 | 2000-08-25 | Inst Francais Du Petrole | DEVICE FOR THE CONTINUOUS REGULATION OF THE COMPOSITION OF A MIXTURE OF COMPONENTS AND SYSTEM FOR SEPARATING CONSTITUENTS INCORPORATING THIS ANALYSIS DEVICE |
JP2000044983A (en) * | 1998-07-31 | 2000-02-15 | Maruha Corp | Method for purifying fatty acid having double bond or derivative thereof |
DK1128881T3 (en) | 1998-10-29 | 2005-10-03 | Inst Francais Du Petrole | Method of separation with chromatographic regions of variable length |
US6413419B1 (en) | 1998-10-29 | 2002-07-02 | Institut Francais Du Petrole | Process and device for separation with variable-length chromatographic |
FR2785196B1 (en) | 1998-10-29 | 2000-12-15 | Inst Francais Du Petrole | METHOD AND DEVICE FOR SEPARATION WITH VARIABLE LENGTH CHROMATOGRAPHIC AREAS |
US6375839B1 (en) | 1998-10-29 | 2002-04-23 | Institut Francais Du Petrole | Process and device for separation with variable-length chromatographic zones |
NO312973B1 (en) | 1999-02-17 | 2002-07-22 | Norsk Hydro As | Lipase-catalyzed esterification of marine oils |
IT1308613B1 (en) | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS. |
JP2000280663A (en) | 1999-03-30 | 2000-10-10 | Dainippon Printing Co Ltd | Id card and method for discriminating it |
JP2001072993A (en) | 1999-06-28 | 2001-03-21 | Nisshin Flour Milling Co Ltd | Method for selective separation and purification of eicosapentaenoic acid and docosahexaenoic acid or ester thereof |
CA2311974A1 (en) | 1999-06-28 | 2000-12-28 | Nisshin Flour Milling Co., Ltd. | Processes of selectively separating and purifying eicosapentaenoic and docosahexaenoic acids or their esters |
WO2001033210A1 (en) | 1999-11-02 | 2001-05-10 | Daicel Chemical Industries, Ltd | Simulated moving bed device |
JP4170542B2 (en) | 1999-11-18 | 2008-10-22 | 日油株式会社 | Process for producing highly unsaturated fatty acid derivative and high-purity eicosapentaenoic acid derivative |
CA2290885A1 (en) | 1999-12-02 | 2001-06-02 | Universite De Sherbrooke | Method for processing harbour seal tissues |
ATE406345T1 (en) | 1999-12-09 | 2008-09-15 | Archer Daniels Midland Co | PURIFICATION OF AMINO ACIDS BY CHROMATOGRAPHIC SIMULATED WALKING BED SEPARATION |
JP2001240893A (en) * | 1999-12-20 | 2001-09-04 | Q P Corp | Method of purifying eiosapentaenoic acid or its derivative |
DK1250058T3 (en) | 2000-01-14 | 2009-05-04 | Epax As | Marine lipid composition for feeding aquatic organisms |
ES2324975T3 (en) | 2000-01-14 | 2009-08-21 | Epax As | METHOD FOR THE CROP OF ADA RICH ORGANISMS IN ADH FOR AQUATIC SPECIES. |
US20020010566A1 (en) | 2000-04-11 | 2002-01-24 | Chester Thomas Lee | Methods for modeling, predicting, and optimizing high performance liquid chromatography parameters |
WO2001087451A2 (en) | 2000-05-16 | 2001-11-22 | Purdue Research Foundation | Standing wave design of a nine-zone smb for the recovery of a solute with intermediate affinity in a ternary mixture |
WO2001087452A2 (en) | 2000-05-16 | 2001-11-22 | Purdue Research Foundation | Standing wave design of single and tandem simulated moving beds for resolving multicomponent mixtures |
AU2001274837A1 (en) | 2000-05-16 | 2001-11-26 | Purdue Research Foundation | Insulin purification using simulated moving bed technology |
DE60022987T2 (en) | 2000-05-22 | 2006-10-19 | Pro Aparts - Investimentos E Consultoria Lda., Funchal | Fatty acid composition containing at least 80% by weight of EPA and DHA |
FR2810897B1 (en) | 2000-06-28 | 2002-10-11 | Novasep | MOBILE BED SEPARATION METHOD AND DEVICE SIMULATES AT LEAST ONE CONSTITUENT IN COLUMNS HAVING AN APPROPRIATE LENGTH TO DIAMETER RATIO |
KR20010008387A (en) | 2000-11-30 | 2001-02-05 | 이성권 | Method for producing highly pure unsaturated fatty acid using crystallization |
FR2823134B1 (en) | 2001-04-10 | 2003-09-19 | Novasep | CHROMATOGRAPHIC BED PROTECTION DEVICE IN CHROMATOGRAPHIC COLUMNS WITH DYNAMIC AXIAL COMPRESSION |
FI20010977A (en) | 2001-05-09 | 2002-11-10 | Danisco Sweeteners Oy | Chromatographic separation method |
US20030216543A1 (en) | 2001-05-16 | 2003-11-20 | Wang Nien-Hwa Linda | Insulin purification using simulated moving bed technology |
DE10151155A1 (en) | 2001-10-19 | 2003-05-08 | Nutrinova Gmbh | Native PUFA triglyceride mixtures with a high content of polyunsaturated fatty acids as well as processes for their production and their use |
FR2836230B1 (en) | 2002-02-15 | 2004-04-23 | Novasep | PROTECTION OF THE CHROMATOGRAPHIC BED IN CHROMATOGRAPHY DEVICES WITH DYNAMIC AXIAL COMPRESSION |
FR2836396B1 (en) | 2002-02-22 | 2004-06-18 | Novasep | METHOD AND DEVICE FOR CHROMATOGRAPHY WITH SOLVENT RECOVERY |
SE0202188D0 (en) | 2002-07-11 | 2002-07-11 | Pronova Biocare As | A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
EP2295529B2 (en) | 2002-07-11 | 2022-05-18 | Basf As | Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use |
KR100481663B1 (en) | 2002-09-24 | 2005-04-08 | 김희찬 | Biosensor contained mesoporous platinum and method of determining concentration using same |
EP2966172B1 (en) | 2002-10-11 | 2018-02-21 | Nippon Suisan Kaisha, Ltd. | Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil |
FR2846252B1 (en) | 2002-10-29 | 2005-07-01 | Novasep | CHROMATOGRAPHY METHOD AND DEVICE INTEGRATING A CONCENTRATION STEP |
NO319194B1 (en) | 2002-11-14 | 2005-06-27 | Pronova Biocare As | Lipase-catalyzed esterification process of marine oils |
US7114844B2 (en) | 2003-03-03 | 2006-10-03 | Spx Corporation | Aeration apparatus and method |
ITMI20032247A1 (en) | 2003-11-19 | 2005-05-20 | Tiberio Bruzzese | INTERACTION OF POLAR DERIVATIVES OF COMPOUNDS INSATURATED WITH INORGANIC SUBSTRATES |
ES2563649T3 (en) | 2003-12-30 | 2016-03-15 | Dsm Ip Assets B.V. | Deaeration Process |
MY150129A (en) | 2004-04-09 | 2013-11-29 | Archer Daniels Midland Co | Method of preparing fatty acid alkyl esters from waste or recycled fatty acid stock |
US20060086667A1 (en) | 2004-09-13 | 2006-04-27 | Cephalon, Inc., U.S. Corporation | Methods for the separation of enantiomeric sulfinylacetamides |
JP4652774B2 (en) | 2004-11-09 | 2011-03-16 | ダイセル化学工業株式会社 | Simulated moving bed chromatography separation device and method for producing target substance using the same |
FR2889077B1 (en) | 2005-07-26 | 2007-10-12 | Novasep Soc Par Actions Simpli | METHOD AND DEVICE FOR CHROMATOGRAPHIC SEPARATION OF FRACTIONS OF A MIXTURE |
ITMI20051560A1 (en) * | 2005-08-10 | 2007-02-11 | Tiberio Bruzzese | COMPOSITION OF N-3 FATTY ACIDS WITH HIGH CONCENTRATION OF EPA AND E-O DHA AND CONTAINING N-6 FATTY ACIDS |
PE20070482A1 (en) | 2005-08-26 | 2007-06-08 | Ocean Nutrition Canada Ltd | METHOD TO REMOVE AND / OR REDUCE STEROLS FROM OILS |
US7544293B2 (en) | 2005-09-26 | 2009-06-09 | Semba Inc. | Valve and process for interrupted continuous flow chromatography |
EP1979062B1 (en) | 2005-12-16 | 2014-09-10 | Archer-Daniels-Midland Company | Method of preparing a composition using argentation chromatography |
US7828978B2 (en) | 2006-01-11 | 2010-11-09 | Doug Geier | Simultaneous synthesis and purification of a fatty acid monoester biodiesel fuel |
JP2009526033A (en) * | 2006-02-07 | 2009-07-16 | オメガトリ エーエス | Omega 3 |
FR2897277B1 (en) | 2006-02-10 | 2008-04-18 | Novasep Soc Par Actions Simpli | METHOD AND DEVICE FOR SEPARATION |
FR2897238A1 (en) | 2006-02-15 | 2007-08-17 | Novasep Soc Par Actions Simpli | Method of extraction and purification of thaumatin comprises clarification, enzymatic treatment and passage of thaumatin on strong anion exchange resin, followed by ultrafiltration/diafiltration, crystallization and drying |
FR2898064A1 (en) | 2006-03-03 | 2007-09-07 | Novasep Soc Par Actions Simpli | MODULAR CHROMATOGRAPHY DEVICE |
FR2898283B1 (en) | 2006-03-08 | 2011-07-15 | Novasep | METHOD AND DEVICE FOR SEPARATING FRACTIONS FROM A MIXTURE |
JP2009529891A (en) | 2006-03-15 | 2009-08-27 | マーテック バイオサイエンシーズ コーポレーション | Plant seed oil containing polyunsaturated fatty acids |
EP2006389B1 (en) | 2006-04-13 | 2017-05-31 | Nippon Suisan Kaisha, Ltd. | Process for preparing concentrated polyunsaturated fatty acid oil |
WO2008149177A2 (en) | 2006-05-05 | 2008-12-11 | Natural Asa | Marine lipid compositions and uses thereof |
WO2007144476A1 (en) | 2006-06-16 | 2007-12-21 | Groupe Novasep | Multi-column sequence separation method |
WO2007147554A2 (en) | 2006-06-19 | 2007-12-27 | K.D. Pharma Bexbach Gmbh | Improved cromatography process for recovering a substance or a group of substances from a mixture |
CA2656311C (en) | 2006-07-05 | 2016-06-21 | Photonz Corporation Limited | Ultra pure epa and polar lipids produced in largely heterotrophic culture |
WO2008025887A1 (en) | 2006-08-28 | 2008-03-06 | Novasep | Method for enriching one or more compounds of a mixture using a liquid mobile phase containing a gas |
JP2008061571A (en) | 2006-09-07 | 2008-03-21 | Toyomac Ltd | Method for producing liquid oil and fat for animal feeding stuff, and mixed animal feeding stuff |
NO325550B1 (en) | 2006-10-31 | 2008-06-16 | Due Miljo As | Procedures for the purification of oils and their use in food and feed |
FR2911793B1 (en) | 2007-01-26 | 2010-07-30 | Novasep | CHROMATOGRAPHY SEPARATION PROCESS |
DE502007004854D1 (en) | 2007-04-17 | 2010-10-07 | Max Planck Gesellschaft | Method and apparatus for the chromatographic separation of components with partial recycling of mixture fractions |
WO2008153472A1 (en) | 2007-06-15 | 2008-12-18 | Ge Healthcare Bio-Sciences Ab | Chromatography method |
US20090023808A1 (en) | 2007-06-29 | 2009-01-22 | Martek Biosciences Corporation | Production and Purification of Esters of Polyunsaturated Fatty Acids |
WO2009014452A1 (en) | 2007-07-25 | 2009-01-29 | Epax As | Omega-3 fatty acid fortified composition |
FR2919200B1 (en) | 2007-07-27 | 2009-10-30 | Novasep | CONTINUOUS CRYSTALLIZATION PROCESS |
CN101765662B (en) | 2007-07-30 | 2014-04-02 | 日本水产株式会社 | Process for production of EPA-enriched oil and DHA-enriched oil |
CA2715328A1 (en) | 2008-02-21 | 2009-08-27 | Dow Global Technologies Inc. | Separation of natural oil-derived aldehydes or hydroxy methyl esters using process chromatography |
FR2929533B1 (en) | 2008-04-03 | 2010-04-30 | Novasep | MULTICOLOUR GRADIENT SEPARATION PROCESS. |
KR101357298B1 (en) | 2008-06-20 | 2014-01-28 | 에이케이 앤 엠엔 바이오팜 주식회사 | Purification and concentration method of high purity omega-3 polyunsaturated fatty acids |
WO2010018422A1 (en) | 2008-08-14 | 2010-02-18 | Novasep | Process for the enrichment of isotopes |
CN104146955A (en) | 2009-03-09 | 2014-11-19 | 普罗诺瓦生物医药挪威公司 | Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof |
MX2011011538A (en) | 2009-04-29 | 2012-06-13 | Amarin Pharma Inc | Stable pharmaceutical composition and methods of using same. |
EP2319329A1 (en) | 2009-10-22 | 2011-05-11 | Consejo Superior De Investigaciones Científicas (CSIC) | High melting point sunflower fat for confectionary |
ES2862980T3 (en) * | 2009-12-30 | 2021-10-08 | Basf Pharma Callanish Ltd | Polyunsaturated Fatty Acid Compositions Obtainable by Simulated Moving Bed Chromatographic Separation Process |
GB201111591D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Further new process |
GB201111589D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New modified process |
GB201111595D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Improved process |
GB201111594D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
GB201111601D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New process |
-
2010
- 2010-12-24 ES ES13154052T patent/ES2862980T3/en active Active
- 2010-12-24 CA CA2785742A patent/CA2785742C/en active Active
- 2010-12-24 KR KR1020127020135A patent/KR101761959B1/en active IP Right Grant
- 2010-12-24 AU AU2010338031A patent/AU2010338031B2/en not_active Ceased
- 2010-12-24 DK DK10818131.4T patent/DK2519332T3/en active
- 2010-12-24 RU RU2012131913/05A patent/RU2538981C2/en not_active IP Right Cessation
- 2010-12-24 CA CA3000662A patent/CA3000662C/en active Active
- 2010-12-24 CN CN201080064359.5A patent/CN102811781B/en active Active
- 2010-12-24 CA CA2873141A patent/CA2873141C/en active Active
- 2010-12-24 JP JP2012546499A patent/JP5872483B2/en active Active
- 2010-12-24 BR BR112012016308-6A patent/BR112012016308B1/en active IP Right Grant
- 2010-12-24 PE PE2012000901A patent/PE20130491A1/en active IP Right Grant
- 2010-12-24 PT PT108181314T patent/PT2519332E/en unknown
- 2010-12-24 EP EP20208062.8A patent/EP3865469A3/en active Pending
- 2010-12-24 ES ES10818131.4T patent/ES2459951T3/en active Active
- 2010-12-24 KR KR1020177020219A patent/KR101801011B1/en active IP Right Grant
- 2010-12-24 RU RU2014146265/05A patent/RU2014146265A/en not_active Application Discontinuation
- 2010-12-24 US US13/519,618 patent/US9321715B2/en active Active
- 2010-12-24 PL PL10818131T patent/PL2519332T3/en unknown
- 2010-12-24 EP EP10818131.4A patent/EP2519332B1/en active Active
- 2010-12-24 EP EP13154052.8A patent/EP2591778B1/en active Active
- 2010-12-24 CN CN201510278939.9A patent/CN104974030A/en active Pending
- 2010-12-24 WO PCT/GB2010/002339 patent/WO2011080503A2/en active Application Filing
-
2015
- 2015-01-23 JP JP2015010829A patent/JP6474621B2/en active Active
- 2015-09-30 US US14/870,873 patent/US9790162B2/en active Active
-
2017
- 2017-11-01 JP JP2017211856A patent/JP2018058850A/en not_active Withdrawn
-
2019
- 2019-02-12 JP JP2019022763A patent/JP6987804B2/en active Active
-
2021
- 2021-11-30 JP JP2021195019A patent/JP7364651B2/en active Active
-
2023
- 2023-10-05 JP JP2023173383A patent/JP2024012306A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985589A (en) | 1957-05-22 | 1961-05-23 | Universal Oil Prod Co | Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets |
FR2103302A5 (en) | 1970-07-23 | 1972-04-07 | Toray Industries | |
US3761533A (en) | 1970-07-23 | 1973-09-25 | Toray Industries | Separation process of components of feed mixture utilizing solid sorbent |
US3706812A (en) | 1970-12-07 | 1972-12-19 | Universal Oil Prod Co | Fluid-solid contacting apparatus |
US3696107A (en) | 1971-05-27 | 1972-10-03 | Richard W Neuzil | Improved hydrocarbon separation process |
US4764276A (en) | 1984-07-30 | 1988-08-16 | Advanced Separation Technologies Incorporated | Device for continuous contacting of fluids and solids |
FR2651148A1 (en) | 1989-08-28 | 1991-03-01 | Inst Francais Du Petrole | CONTINUOUS PROCESS AND DEVICE FOR CHROMATOGRAPHIC SEPARATION OF A MIXTURE OF AT LEAST THREE CONSTITUENTS IN THREE EFFLUENTS PURIFIED BY TWO SOLVENTS. |
FR2651149A1 (en) | 1989-08-28 | 1991-03-01 | Inst Francais Du Petrole | CONTINUOUS PROCESS AND DEVICE FOR CHROMATOGRAPHIC SEPARATION OF A MIXTURE OF AT LEAST THREE CONSTITUENTS IN THREE PURIFIED EFFLUENTS USING A SINGLE SOLVENT AT TWO TEMPERATURES AND / OR AT TWO DIFFERENT PRESSURES. |
US5069883A (en) | 1989-10-20 | 1991-12-03 | Progress Water Technologies Corp. | Device for continuous contacting of liquids and solids |
EP0697034A1 (en) | 1993-04-29 | 1996-02-21 | Norsk Hydro As | Processes for chromatographic fractionation of fatty acids and their derivatives |
US6979402B1 (en) | 2003-12-19 | 2005-12-27 | Uop Llc | Miniature actual moving bed assembly |
Non-Patent Citations (2)
Title |
---|
"Preparative and Production Scale Chromatography", 1993, MARCEL DEKKER INC |
WIJESUNDERA, R.C. ET AL., JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, vol. 66, no. 12, 1989, pages 1822 - 1830 |
Cited By (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9790162B2 (en) | 2009-12-30 | 2017-10-17 | Basf Pharma (Callanish) Limited | Simulated moving bed chromatographic separation process |
WO2012109545A2 (en) | 2011-02-11 | 2012-08-16 | E. I. Du Pont De Nemours And Company | Method for obtaining a lipid-containing composition from microbial biomass |
US8999663B2 (en) | 2011-02-11 | 2015-04-07 | E L Du Pont De Nemours And Company | Method for obtaining a lipid-containing composition from microbial biomass |
JP2014528907A (en) * | 2011-06-16 | 2014-10-30 | イエフペ エネルジ ヌヴェルIfp Energies Nouvelles | Method and apparatus for pseudo-countercurrent chromatographic separation with low pressure drop and high zone bed number |
EP3238800A1 (en) * | 2011-07-06 | 2017-11-01 | BASF Pharma (Callanish) Limited | Heated chromatographic separation process |
US9370730B2 (en) | 2011-07-06 | 2016-06-21 | Basf Pharma Callanish Limited | SMB process |
US9315762B2 (en) | 2011-07-06 | 2016-04-19 | Basf Pharma Callanish Limited | SMB process for producing highly pure EPA from fish oil |
KR101757132B1 (en) | 2011-07-06 | 2017-07-12 | 바스프 파마 (칼라니쉬) 리미티드 | Smb process for producing highly pure epa from fish oil |
US9771542B2 (en) | 2011-07-06 | 2017-09-26 | Basf Pharma Callanish Ltd. | Heated chromatographic separation process |
WO2013005047A1 (en) * | 2011-07-06 | 2013-01-10 | Basf Pharma (Callanish) Limited | Heated chromatographic separation process |
US9234157B2 (en) | 2011-07-06 | 2016-01-12 | Basf Pharma Callanish Limited | SMB process |
US9260677B2 (en) | 2011-07-06 | 2016-02-16 | Basf Pharma Callanish Limited | SMB process |
US9347020B2 (en) | 2011-07-06 | 2016-05-24 | Basf Pharma Callanish Limited | Heated chromatographic separation process |
US9695382B2 (en) | 2011-07-06 | 2017-07-04 | Basf Pharma (Callanish) Limited | SMB process for producing highly pure EPA from fish oil |
AU2012280066B2 (en) * | 2011-07-06 | 2015-06-11 | Basf Pharma (Callanish) Limited | Heated chromatographic separation process |
EP3906983A1 (en) * | 2011-07-06 | 2021-11-10 | BASF Pharma (Callanish) Limited | Heated chromatographic separation process |
EP2613862B1 (en) * | 2011-07-06 | 2018-12-19 | BASF Pharma (Callanish) Limited | New smb process |
EP2732014A1 (en) | 2011-07-14 | 2014-05-21 | Soluciones Extractivas Alimentarias, S.L. | New process for reducing pollutants in fats and oils and their derivatives |
WO2013083482A1 (en) * | 2011-12-05 | 2013-06-13 | Chromacon Ag | Chromatographic method for the separation of fatty acid mixtures |
EP2661483A4 (en) * | 2012-01-04 | 2015-08-26 | Naturalis S A | Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil |
WO2013102800A1 (en) | 2012-01-04 | 2013-07-11 | Naturalis S.A. | Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil |
US10399922B2 (en) | 2012-05-14 | 2019-09-03 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
CN104302615A (en) * | 2012-05-14 | 2015-01-21 | 日本水产株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
CN104302615B (en) * | 2012-05-14 | 2017-09-08 | 日本水产株式会社 | Reduce the highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester and its manufacture method of environmental pollutants |
US10399923B2 (en) | 2012-05-14 | 2019-09-03 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
US11034643B2 (en) | 2012-05-14 | 2021-06-15 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
EP2851361B1 (en) | 2012-05-14 | 2021-11-24 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
JP2017190335A (en) * | 2012-05-14 | 2017-10-19 | 日本水産株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutant and manufacturing method therefor |
US11603347B2 (en) | 2012-05-14 | 2023-03-14 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
WO2013172346A1 (en) * | 2012-05-14 | 2013-11-21 | 日本水産株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
JPWO2013172346A1 (en) * | 2012-05-14 | 2016-01-12 | 日本水産株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants and method for producing the same |
US9540306B2 (en) | 2012-05-14 | 2017-01-10 | Nippon Suisan Kaisha, Ltd. | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same |
JP2014231513A (en) * | 2012-05-14 | 2014-12-11 | 日本水産株式会社 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing the same |
CN104321295B (en) * | 2012-05-23 | 2016-05-25 | 欧罗彻姆技术公司 | For method and adsorbent from biofermentation system separating alcohol and relevant oxygenatedchemicals |
WO2013177056A1 (en) * | 2012-05-23 | 2013-11-28 | Orochem Technologies, Inc. | Process and adsorbent for separating ethanol and associated oxygenates from a biofermentation system |
CN104321295A (en) * | 2012-05-23 | 2015-01-28 | 欧罗彻姆技术公司 | Process and adsorbent for separating ethanol and associated oxygenates from a biofermentation system |
US10039734B2 (en) | 2012-12-24 | 2018-08-07 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US9629820B2 (en) | 2012-12-24 | 2017-04-25 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10123986B2 (en) | 2012-12-24 | 2018-11-13 | Qualitas Health, Ltd. | Eicosapentaenoic acid (EPA) formulations |
US10214475B2 (en) | 2013-01-09 | 2019-02-26 | Basf Pharma (Callanish) Limited | Multi-step separation process |
JP2017094323A (en) * | 2013-01-09 | 2017-06-01 | バスフ ファーマ(カラニッシュ)リミテッド | Multi-step separation method |
US9694302B2 (en) | 2013-01-09 | 2017-07-04 | Basf Pharma (Callanish) Limited | Multi-step separation process |
KR101986061B1 (en) | 2013-01-09 | 2019-06-04 | 바스프 파마 (칼라니쉬) 리미티드 | Multi-step separation process |
RU2638206C2 (en) * | 2013-01-09 | 2017-12-12 | Басф Фарма (Калланиш) Лимитед | Multistage separation method |
JP2017223677A (en) * | 2013-01-09 | 2017-12-21 | バスフ ファーマ(カラニッシュ)リミテッド | Multi-step separation method |
US10723973B2 (en) | 2013-01-09 | 2020-07-28 | Basf Pharma (Callanish) Limited | Multi-step separation process |
KR20180100708A (en) * | 2013-01-09 | 2018-09-11 | 바스프 파마 (칼라니쉬) 리미티드 | Multi-step separation process |
US10179759B2 (en) * | 2013-01-09 | 2019-01-15 | Basf Pharma (Callanish) Limited | Multi-step separation process |
JP2016513452A (en) * | 2013-03-07 | 2016-05-16 | アルジシス,エルエルシー | Production of omega-3 fatty acids from phytium species |
EP2801604A1 (en) | 2013-05-07 | 2014-11-12 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
WO2014180654A1 (en) | 2013-05-07 | 2014-11-13 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
EP2801604B1 (en) | 2013-05-07 | 2017-04-12 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US11330817B2 (en) | 2013-12-04 | 2022-05-17 | Nippon Suisan Kaisha, Ltd. | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil |
US11856952B2 (en) | 2013-12-04 | 2024-01-02 | Nippon Suisan Kaisha, Ltd. | Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil |
WO2015086607A1 (en) | 2013-12-11 | 2015-06-18 | Novasep Process | Method for chromatographic purification of a fatty acid |
WO2015086591A1 (en) | 2013-12-11 | 2015-06-18 | Novasep Process | Purification of fatty acids by a chromatographic method |
WO2015086672A1 (en) | 2013-12-11 | 2015-06-18 | Novasep Process | Chromatographic method for producing polyunsaturated fatty acids |
EP2883860A1 (en) | 2013-12-11 | 2015-06-17 | Novasep Process | Chromatographic method for producing polyunsaturated fatty acids |
EP3473318A1 (en) | 2013-12-11 | 2019-04-24 | Novasep Process | Method for chromatographic purification of a fatty acid |
US9150816B2 (en) | 2013-12-11 | 2015-10-06 | Novasep Process Sas | Chromatographic method for the production of polyunsaturated fatty acids |
EP3118186A1 (en) | 2013-12-11 | 2017-01-18 | Novasep Process | Chromatographic facility for producing polyunsaturated fatty acids |
US10975031B2 (en) | 2014-01-07 | 2021-04-13 | Novasep Process | Method for purifying aromatic amino acids |
US10864185B2 (en) | 2014-09-17 | 2020-12-15 | Nippon Suisan Kaisha, Ltd. | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same |
US11648229B2 (en) | 2014-09-17 | 2023-05-16 | Nippon Suisan Kaisha, Ltd. | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same |
AU2016281819B2 (en) * | 2015-06-26 | 2021-10-14 | Pronova Biopharma Norge As | Composition for treatment of NAFLD |
WO2016207734A1 (en) * | 2015-06-26 | 2016-12-29 | Pronova Biopharma Norge As | Composition for treatment of nafld |
WO2023111317A1 (en) | 2021-12-17 | 2023-06-22 | Basf Se | Chromatographic separation process for efficient purification of polyunsaturated fatty acids |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9790162B2 (en) | Simulated moving bed chromatographic separation process | |
US9370730B2 (en) | SMB process | |
EP2613861B1 (en) | Improved smb process | |
EP2613862B1 (en) | New smb process | |
AU2013204090B2 (en) | Simulated moving bed chromatographic separation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080064359.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10818131 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010338031 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2785742 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 000901-2012 Country of ref document: PE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012546499 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010818131 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2010338031 Country of ref document: AU Date of ref document: 20101224 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20127020135 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012131913 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13519618 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012016308 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012016308 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120629 |